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Optic neuritis (ON) is frequently a first sign of multiple sclerosis (MS), which is an 
inflammatory demyelinative disease of the central nerve system (CNS), including brain, optic 
nerve, and spinal cord. Investigating ON provides an approach to improve MS diagnosis and 
treatment monitoring. Experimental autoimmune encephalomyelitis (EAE) is a widely used 
animal model of MS and exhibits pathologies similar to the human disease. Magnetic resonance 
imaging (MRI) is a non-invasive tool to detect disease progress and as a standard diagnose 
procedure for MS in the clinic. In biological samples, the hydrogen nuclei are used to produce 
the MR signal due to its abundance in water and fat.  As a result of tissue microstructural 
differences, 
1
H nuclei exhibit tissue-specific and pathology-specific relaxation and diffusion 
properties, which are reflected in the resulting MR image contrast. Therefore, the pathologies of 
MS, such as inflammation, demyelination, and axonal injury can be detected using different MR-
related tools, including T1- and T2-weighted imaging, diffusion-weighted imaging, and diffusion 
tensor imaging, and so on. Importantly, direct non-invasive assessment of functional deficits 
could be important for understanding pathology mechanisms or provide a useful bio-index to 
xiv 
 
validate treatment strategies. In this dissertation, manganese-enhanced MRI (MEMRI) and 
diffusion fMRI were introduced to explore the functional deficits, including axonal transport 
disruption and axon-activity dysfunction, at optic neuritis onset in EAE mice. 
. 
 
  
1 
 
Chapter 1 
Introduction 
1.1 Multiple Sclerosis 
Multiple sclerosis (MS) is an inflammatory demyelinating disease that mainly affects the 
central nervous system (CNS) such as brain, optic nerve and spinal cord (Fig. 1 – 1), usually 
diagnosed in young adults [1, 2]. Main symptoms include impaired vision, extreme fatigue, 
spasms, and paralysis of a variety of muscle systems [3].  Hallmarks of MS include focal 
inflammatory infiltration, demyelination, oligodendrocyte depletion,  and axonal degeneration 
[4]. Around 85% of all MS cases initially develop relapsing-remitting MS (RR-MS, Fig. 1 – 2A), 
characterized by episodes of neurological disability and return to baseline. Approximately 50% 
of RR-MS patients, so-called secondary progressive MS (SP-MS, Fig. 1 – 2B), show relapses but 
clinical disability worsens over time. While people with SP-MS experience fewer relapses, the 
disability worsens and symptoms might become more severe. There is another 10% of all MS 
cases called primary progressive MS (PP-MS, Fig. 1 – 2C), chracterized by steadily worsening 
clinical disability. The final 5% of all MS cases, called progressive relapsing MS (PR-MS, Fig. 1 
– 2D), is characterized by steady worsening of disability along with occasional relapses [5, 6]. 
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Figure 1 – 1 Disease process of MS is believed to start when lymphocytes cross the blood-brain 
barrier (BBB) and attack the myelin sheaths in CNS.  Ultimately, it leads to axonal 
injury/degeneration. 
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Figure 1 – 2 Types of MS (left to right; top to bottom): relapsing-remitting (A), secondary 
progressive (B), primary progressive and (C) progressive relapsing (D) 
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1.2 Disease Process of Multiple Sclerosis 
It is believed that most MS starts with increased migration of  lymphocytes across the 
blood-brain barrier (BBB) [4]. The lymphocyte-derived inflammation causes oligodendrocyte-
associated demyelination which then blocks or slows propagation of electrical signals by white-
matter axons (Fig. 1 – 3). In demyelinated axons, increased sodium channels redistribute 
homogeneously along axons to maintain conduction propagation, therefore, energy demand 
should be higher than usual to support extra regulation (Fig. 1 – 4). Importantly, mitochondria 
provide energy in form of ATP in CNS to maintain regular function, including conduction 
propagation and transport of proteins and organelles [7, 8]. However, due to acute inflammation, 
activated microglia and macrophages produce nitric oxide (NO), which can act to inhibit 
mitochondrial energy production, leading to diminished ATP. Therefore, this leads to 
dysfunction of energy-consuming Na
+
/K
+
 ATPase pump and Na
+
/Ca
2+
 exchanger and eventually 
Ca
2+
 overload, which is directly associated with mitochondrial dysfunction. One consequence of 
this compromised cellular energetic status is a dysfunction of electrical signal propagation and 
axonal transport.  Another serious consequence is a disruption of axonal protein and organelle 
transport along the length of the axons, required to maintain regular function, which further 
contributes to  mitochondrial failure, leading to axonal injury and degeneration, [9, 10, 2, 11-15]. 
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Figure 1 – 3 Electrical signal (action potential) propagation in myelinated and demyelinated 
axons. In MS, activated microglial cells attack myelin sheaths in CNS and lead to demyelination. 
The left-hand side of the figure shows fast signal propagation in myelinated axon. The 
membrane electrical disturbances jump between consecutive nodes of Ranvier. The right-hand 
side shows that electrical signal propagation in demyelinated axon is slowed due to non-saltatory 
membrane conduction (flat arrows).    
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Figure 1 – 4 Sodium channels are increased and redistributed along demyelinated axons to main 
electrical signal (action potential) propagation.  
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1.3 Optic Neuritis of Multiple Sclerosis 
Optic neuritis is an inflammatory disorder of the optic nerve and is the first sign of MS in 
66% of cases (Fig. 1 – 5). Typically, MS patients with optic neuritis have sudden mono-ocular 
visual loss and/or pain [16, 17]. The ten- and fifteen-year risk of developing clinical MS 
following a single episode of optic neuritis is 38% and 50%, respectively [16, 18]. Hence, 
investigating the etiology and treatment of optic neuritis might be crucial to reduce later 
development of MS and long-term disability due to the significant relationship between MS and 
optic neuritis [19].  In general, patients are examined by vision tests (i.e. visual acuity, color 
vision, etc.) and diagnosis is confirmed with visual evoke potential (VEP), magnetic resonance 
imaging (MRI) and optical coherence tomography (OCT) [20]. VEP tests are recordings of the 
nervous system’s electrical response to visual stimulation and might highlight demyelination 
which delays or blocks electrical potential propagation [21]. MRI could provide a non-invasive 
means to diagnose the lesion in CNS [18, 22]. OCT is a non-invasive measurement using 
infrared light to reflect retinal thickness, which is associated with axonal and neuronal 
degeneration [23, 24]. 
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Figure 1 – 5 Visual signal is relayed from from retinal ganglion cell axons of the optic nerve via 
synaptic terminalsto the lateral geniculate nucleus (LGN) and superior colliculus (SC). 
Demyelination cancause signal propagation blockage and lead to axonal injury.  
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1.4 Animal Model of Multiple Sclerosis  
Experimental autoimmune encephalomyelitis (EAE) is a widely used animal model of MS 
and can be induced in several species, including mice, rats, non-human primates, and so on. EAE 
is induced by immunization with myelin antigens (active induction) such as myelin 
oligodendrocyte glycoprotein (MOG), myelin basic protein (MBP), and myelin proteolipid 
protein (PLP) or via adoptive transfer of myelin-reactive T cells (passive induction) [5, 25, 26].  
Many of the immune mediators responsible for EAE pathologies have been shown to play a role 
in MS, but there are differences between EAE and MS: the auto-antigen against which the 
immune response is directed is known in EAE, while the etiology of MS is unknown. However, 
EAE models have greatly advanced our understanding of T-cell mediated neuroinflammation. 
For example, heterogeneity of disease is an important feature of both EAE and MS [25].  MOG-
specific EAE in rodents has been shown to include the development of optic neuritis during its 
course [27-29] and provides an appropriate model to investigate optic neuritis of MS.  
1.5 Mouse Visual System and Visual Acuity 
The mouse visual system has become one of the primary models for the study of the 
human visual system. The mouse eye is remarkably similar in structure to the human eye and 
shares similar cell types and structural features. Therefore, studies in the mouse models might 
lead to a better understanding of the mechanism of human disease [30].  Indeed, the mouse visual 
system has been reported to show functional response similar to the human visual system  [31].  
The visual pathway starts from retinal ganglion cells (inner layer of retina), and connects to the 
optic nerve. After the optic chiasm, 95% of optic nerve axons project to the contralateral optic 
tract, lateral geniculate nuclei (LGN), and superior colliculus (SC) [32] (Fig. 1 – 6). 
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To determine if EAE mouse developed optic neuritis, rapid and reproducible behavioral 
assessment of visual-tracking was introduced using Virtual Optometry System (Optomotry, 
Cerebral Mechanics, Inc., Canada) to reflect visual system integrity  [33, 34] (Fig. 1 – 7). Briefly, 
virtual rotating columns were projected on the LCD monitors with different spatial frequencies 
in cycles/degree (c/d). The mouse head movement in response to the virtual column rotations 
was noted. The spatial frequency was incremented from 0.1 c/d with step size of 0.05 c/d until 
the mouse stopped responding. The VA was defined as the highest spatial frequency of virtual 
rotating columns to which the mouse was able to respond. We have previously reported that 
normal VA of C57BL/6 was 0.38 ± 0.03 c/d (mean ± S.D., n=30) and defined VA ≤ 0.25 c/d as 
the onset of acute ON for EAE mice [35]. In Chapter 3 and 4, after immunization, VA of each 
eye was evaluated daily. MRI was performed on mice with VA ≤ 0.25 c/d, the operational 
definition of ON. 
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Figure 1 – 6 Visual system consists of retina, optic nerve, optic chiasm, optic tract, lateral 
geniculate nucleus (LGN), and superior colliculus (SC). Most (~95%) optic nerve after optic 
chiasm corresponds to contralateral LGN and SC (A). After intravitreal Mn
2+
 injection, it goes 
from ipsilateral retina and optic nerve to contralateral LGN and SC (seen details in Chapter 2 and 
3). The real mouse optic nerve and optic chiasm are shown the same structure as A.  
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Figure 1 – 7 Optokinetic response (OKR) reflects mouse visual acuity. The testing apparatus 
was comprised by four LCD monitors (faced inward) with a camera at the top (A). Mouse was 
placed in the testing box surrounding with LCDs. Moving bar graphs were provided on the 
screens with different spatial frequencies (cycle/degree) (B and C); therefore, mouse can see 
thick (lower spatial frequency) or thin (higher spatial frequency) bar graphs.  Direction of 
moving bar graphs can move either clockwise or counterclockwise to test specific left and right 
eye. Operator can track movement of mouse head to determine if mouse responded or not. (Seen 
Section 1.6 for details protocol of operation)  
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1.6 Magnetic Resonance Imaging as a Non-invasive Bio-marker 
Magnetic resonance imaging (MRI) has been a non-invasive approach to the diagnosis of 
MS since the first MR images were acquired in MS patients in the early 1980s [36].  MRI now 
serves as one of the standard diagnostic approaches for MS. Therefore, it is a promising tool in 
assessment of optic neuritis in MS and EAE [1, 37-42]. The inflammation induced 
morphological changes in CNS, including BBB break-down,  inflammation, demyelination, 
axonal injury or degeneration, are validated by gadolinium contrast enhancement image, 
manganese-enhanced MRI (MEMRI), T1- and T2-weighted image, diffusion-weighted imaging 
(DWI), and diffusion-tensor imaging (DTI). According to these approaches, morphological 
features of optic neuritis in MS and EAE are further understood. However, these metrics cannot 
directly assess the functional deficits in optic nerve/white matter in MS and EAE. Since 
functional deficits might precede morphological changes, investigating functional deficits should 
shed light on treatment strategies for optic neuritis that could further prevention of MS. MRI 
might provide an in vivo non-invasive means to ‘monitor’ real-time functional processes. We 
believe that regular axonal activity, including axonal transport (Fig. 1 – 8) and electrical signal 
propagation (Fig. 1 – 3), can be detected by MRI. The following sections will introduce some 
important principles of NMR/MRI and show how we take advantage of these properties to reflect 
biological function.   
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Figure 1 – 8 Axonal transport is crucial to maintain regular function. Motor proteins can move 
along microtubules, the cytoskeleton of axon, within axons to deliver proteins and organelles in 
either anterograde or retrograde direction. 
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1.7 Nuclear Magnetic Resonance and Magnetic Resonance Imaging  
MRI is an advanced application of nuclear magnetic resonance (NMR). NMR began in 
1946 with two independent but simultaneous groups led by Purcell [43] and Bloch [44], 
respectively. The key property of NMR-active nuclei is that they possess spin or intrinsic spin 
angular momentum. However, not all nuclei exhibit spin. Specific isotopes fall into one of three 
groups of spin values, zero, integral, and half-integral. Only integral spin value with an even 
atomic weight and an odd atomic number (e.g. 
2
H) and half-integral spin value with an odd 
atomic weight (e.g. 
1
H, 
23
Na, and 
31
P, etc.) can be detected in NMR. The 
1
H nucleus is the most 
commonly-used nuclei for use in MRI signals. It has a spin of ½ and is the most abundant 
isotope of hydrogen.  
Water molecules, which constitute two third of human/animal body weight, consist of two 
hydrogens and one oxygen atom. Thus water protons account for the bulk of the 
1
H MRI signal 
in biological samples.  In the absence of a magnetic field, protons with ½ spin equally distribute 
between two energy states and thus cancel their collective magnetic effect. In the magnet with 
constant magnetic field B0  ̂, at equilibrium, the fraction of spins that are oriented parallel to the 
direction of B0 is slightly greater than those that  are anti-parallel to B0.  The equilibrium 
population of spin states is by Boltzmann statistics (Eq. 1.1). 
 
       
       
                  (1.1) 
where Nm is the fraction of particle population in each state, k is Boltzmann constant, 1.381 ×10
-
23
 JK
-1
, and T is the absolute temperature in Kelvin.  This unequal population of spin-states 
produces a non-zero net magnetization (vector sum of spin-up and spin-down within the 
ensemble).  
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The corresponding Hamiltonian of the interaction between the spins and B0 field is shown 
in Eq. (1.2) 
                               (1.2) 
where H is the Hamiltonian operator, Ψm is an eigenfunction, Iz is an angular momentum 
operator, γ is gyromagnetic ratio, m is its spin quantum number, B0 is the main magnetic field 
strength, һ is Planck’s constant, 6.626 × 10-34 J·s (ћ is һ divided by 2π), and –mћγB0 is the 
corresponding eigenvalue. The energy gap between two states is shown in Eq. (1.3) (Fig. 1 – 9) 
                                 (1.3) 
                   (1.4)  
A time-varying (varying with frequency ν0 = 0/2), applied perpendicular to B0 magnetic field, 
and typically denoted as B1 can induce transitions between the two spin states. The resonance is 
known as resonance frequency or absorption frequency, which is associated with γ and B0.  
For each proton (microscopic view), the angular momentum is quantized. However, for a 
bulk sample of magnetic dipoles (macroscopic view), the interaction of the net magnetization 
with applied magnetic fields (B0 and/or B1) is conveniently treated using classical mechanics [46] 
(Fig. 1 – 10).  This macroscopic view ignores quantum effects due to the  small order of ћ [45].  
In this classical treatment, the net magnetization precesses in the B0 field with a frequency that is 
the same as the absorption frequency, called the Larmor frequency. 
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Figure 1 – 9 Nuclei that possess spin align themselves to the corresponding energy state in 
magnetic field, so-called Zeeman Effect. The spins are separated into two groups -1/2 (anti-
parallel) and +1/2 (parallel) by magnetic field. Energy gap can correspond to specific resonance 
frequency, so-called Larmor frequency.  
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Figure 1 – 10 For macroscopic view, net magnetization is the vector to represent the 
combination effects of total spins 
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1.7.1 T1 and T2 Relaxation 
Magnetization in magnetic field experiences a torque, which is the rate of change of 
angular momentum (analogous to Newton’s first law that force is the rate of change of 
momentum).  Their relationships could be presented as a motion equation like Eq. (1.5) and (1.6) 
(in rotating frame) 
  
  
   
             (1.5) 
 
  
   
                  (1.6) 
where L = Iω0, µ = γ L, N is a torque, µ is a dipole moment, B is a magnetic field, and γ is a 
gyromagnetic ratio. 
     In addition to precession in the magnetic field, magnetization also experiences 
relaxation. That is, once perturbed from equilibrium, the magnetization gradually tends to 
approach the most-probable (Boltzmann distribution) population of spin-states. Therefore, Bloch 
proposed a set of differential equations to represent precession and relaxation of magnetization in 
magnetic field [44]. If the magnetic field is constant (B0) and in  ̂ direction the equations are as 
follow 
 
   
   
       
  
  
           (1.7)  
 
   
   
        
  
  
          (1.8)  
 
   
   
  
     
  
         (1.9) 
where Mx and My are transverse component of magnetization, M0 is net equilibrium 
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magnetization, Mz is the longitudinal component of net magnetization, M0 is the equilibrium 
magnetization, T1 is a longitudinal relaxation time constant, and T2 is time constant for decay 
of transverse magnetization components. The solutions of Eq. (1.9) is shown in Eq. (1.10) 
           [        ]  
  
 
          (1.10) 
and if we let Mxy = Mx + i My, Eq. (1.7) and (1.8) are rewritten as Eq. (1.11)  
 
    
   
 (
   
   
  
   
   
)   [(     )  
  
  
]   [        
  
  
]   (1.11) 
the solution of transverse magnetization is shown in Eq. (1.12) 
          
         
  
 
        
        
  
 
        (1.12) 
where ω0 = B0 γ, Larmor frequency   
After a 90º RF pulse, the magnetization is flipped to the transverse plane, and decay of 
the net magnetization, viewed in an on-resonance rotating frame (i.e., a reference frame rotating 
about B0 with angular frequency ω0) can represented as Eq. (1.13) 
         
  
 
            (1.13) 
Different tissues have their own specific field-strength-dependent T1 and T2 relaxation 
time constants. MRI takes advantage of this property and utilizes different MR parameters to 
bias measurements based upon T1 or T2 characteristics, so called T1- or T2- weighted images. 
Fig. 1 – 11 demonstrates the different T1 and T2 relaxation times of brain tissue. 
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Figure 1 – 11 White matter (WM), gray matter (GM), and cerebrospinal fluid (CSF) have 
different T1 and T2 relaxation time. The specific MR parameters (i.e. TR or TE) can reveal 
tissue contrast (A). Representative T1- and T2-weighted middle sagittal images of mouse brain 
show different contrast. Image parameter: 30 mm × 30 mm × 1 mm; T1-weighted spin-echo 
sequence with TR = 600 ms, TE = 25 ms, Average = 8; T2-weighted spin-echo sequence with 
TR = 3,000 ms, TE = 100 ms, Average = 4.  
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1.7.2 Diffusion NMR and MRI  
The relationship of Brownian motion (self diffusion) of molecules and diffusivity in 
microscopic view was described by Einstein in 1905 (Eq. (1.14)). 
〈       
 〉                (1.14) 
where  〈       
 〉 is the mean square displacement, D is the diffusion coefficient, and t is the 
time interval. For the case of diffusion in 3-D, the mean square displacement is    .   
Regarding macroscopic view, Fick’s 1st law describes that the movement of molecules 
are from region of high concentration to low concentration by random molecular motion (Eq. 
(1.15)). 
                 (1.15) 
where   is diffusion flux, and   concentration gradient. Conservation of mass during the 
diffusion process implies     
  
  
 . It leads to Fick’s 2nd law (Eq. (1.16)) 
  
  
                   (1.16) 
Torrey proposed that this diffusional motion could be accounted for in the Bloch 
equations by adding an additional term [47]. Subsequently, the new simultaneous equations (Eq. 
(1.17) to Eq. (1.19)) become as below 
   
   
       
  
  
                (1.17) 
   
   
       
  
  
                (1.18) 
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                      (1.19) 
where D is diffusion coefficient 
If the diffusion is isotropic, then, the Bloch-Torrey equations can be re-written as Eq. 
(1.20), (1.21) and (1.22) 
   
   
       
  
  
              (1.20) 
   
   
       
  
  
              (1.21) 
   
   
  
     
  
                    (1.22)  
A decade later (1965), Stejskal and Tanner modified Hahn’s spin echo experiment and  
designed the pulse gradient spin echo (PGSE) experiment with two identical magnetic gradients 
before and after 180º RF pulse to encode the diffusing spin [48, 49] (Fig. 1 – 12). Let us again 
define the complex transverse magnetization as Mxy = Mx + iMy. After adding diffusion terms 
and considering gradients (Bz = B0+G·z, Bx = ½ (G·x) and = ½ (G·y)), Eq. (1.11) is rewritten as 
Eq. (1.23) 
    
   
                  
 
  
        
 
 
              (1.23) 
where ω0 = B0 γ and Mxy, the complex transverse magnetization, which precesses about the z 
axis with angular speed – ω0. Then, Eq. (1.24) is putting in Eq. (1.23) and obtaining Eq. (1.25) 
m =            
  
 
           (1.24) 
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       (1.25) 
the third term of Eq. (1.25) is the order of            , which is assumed to be negligible. 
Therefore, Eq. (1.25) is rewritten as Eq. (1.26) 
  
   
                       (1.26) 
Now, if a constant magnetic field gradient G is applied and is collinear with B0. The 
magnetization precesses in the resulting magnetic field  
                   (1.27) 
the gradient G is assumed uniform through whole sample and r is the position vector for a given 
nucleus. The Eq. (1.26) is rewritten as Eq. (1.28) 
  
   
                       (1.28) 
In the absence of diffusion,  φ in Eq. (1.28) can be written as Eq. (1.29), which represents 
the transverse magnetization at any time point. φ(0) = A represents the transverse magnetization 
immediately after the first 90º RF pulse 
                       (1.29) 
where  
     ∫         
 
 
        
After time τ, at which a 180° refocusing pulse is applied, Eq. (1.29) can be rewritten as Eq. (1.30) 
         [       ]          (1.30) 
where f ≡ F (τ), and it corresponds to the phase angle that has accumulated between 90º and 180º 
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RF pulse, due to the time-varying applied diffusion gradients. If we want to correctly describe 
the magnetization before the 180º RF pulse, the new parameter, ξ = 1 for t < τ and ξ = -1 for t > τ, 
is introduced. Then, the Eq. (1.30) is modified as Eq. (1.31) 
         [           ]         (1.31) 
therefore, after 180º RF pulse, the second exponent is -2f, while the first exponent continues to 
increase from F (τ) to F (2τ). A spin echo is formed when F (2τ) = 2f. Then, the second 
exponential term is equal to one. Stejskal-Tanner assumed that the solution of equation 1.28 with 
diffusion effects would take the same shape as in the non-diffusing case. They also let A be a 
function of time, A(t), in the presence of diffusion. 
Now, the Eq. (1.28) without diffusion is rewritten as Eq. (1.32) 
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]      [           ]      (1.32) 
where  
     
  
                 (1.33) 
and  
  
  
             (1.34) 
The Laplacian term of Eq. (1.28) would be like Eq. (1.35)            
                  [           ] 
         [           ]       [           ]      (1.35) 
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Substituting Eq. (1.35) into the Laplacian term of Eq. (1.28) and equating Eq. (1.32) 
gives  
     
  
         [           ]        (1.36) 
Integrating Eq. (1.36) from t = 0 to t = 2τ gives Eq. (1.37) 
  [
     
    
]      [∫           
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     (1.37) 
where 
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The definition of G (t) in this discrete time interval shows the simplest pulse gradient spin-echo 
(PSGE) (Fig. 1 – 7). The final result of Eq. (1.37) is shown in Eq. (1.38) 
  [
      
    
]          (  
 
 
)        (1.38) 
where  
        (  
 
 
)           (1.39) 
Eq. (1.38) is the famous Stejskal-Tanner equation, and b value (Eq. (1.39)), the so-called 
gradient-sensitization parameter, reflects how diffusion is weighted by G (the gradient strength), 
δ (the duration of each gradient pulse), and Δ (the time between the two gradient pulses). D is a 
diffusion coefficient, γ is gyromagnetic ratio, and the effective diffusion time (T) is Δ – δ/3. 
Subsequently, according to Stejskal and Tanners’ report, applied pulse gradient reduced signal 
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intensities (Fig. 1 – 13). According to Eq. (1.38), diffusion coefficient, D, is calculated from two 
different intensities, A (2τ) and A (0), and two different b values. 
Tissues are highly heterogeneous media that consists of various compartments and 
barriers. Thus, water molecules are restricted by microstructures and interact with cell 
membranes, and intracellular organelles [50]. The diffusion coefficient of water molecules is not 
free. Therefore, Le Bihan introduced the apparent diffusion coefficient (ADC) [51] to replace 
physical diffusion coefficient D. Diffusion MRI provides an approach to observe the water 
displacement in tissues and reveals information about the presence of microscopic 
obstacles/structures and geometric organization of tissues by ADC (Fig. 1 – 14). 
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Figure 1 – 12 Stejskal-Tanner Pulse-Gradient Spin-Echo with square-wave diffusion sensitizing 
gradients. G is gradient strength, δ is duration of diffusion sensitizing gradient, Δ is time interval 
between diffusion-sensitizing gradient pair, and τ is the time interval between 90º and 180º RF 
pulses.  
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Figure 1 – 13 According to Stejskal-Tanner equation (Eq. (1.38)), applied pulse gradient 
reduced signal intensity (there was phase difference among spins, and net magnetization was 
decreased).Figure shows signal attenuation curves (mono-exponential decay) with different b 
values (only changing gradient strengths) either parallel or perpendicular to mouse optic nerve 
(highly coherent white-matter tract). The overall signal with gradient direction perpendicular to 
optic nerve was higher than the other direction since spins were ‘trapped’ within and by 
cylindrical axonal fibers, and thus could not easily move. When the diffusion gradient was 
applied along the optic nerve, spins were not restricted by optic nerve. Subsequently, they were 
affected by applied gradients easily and resulted in reduced signal due to obvious phase 
difference. Signal decay for b values less than 1.4 and 0.7 ms/μm2 for perpendicular and parallel 
direction was close to mono-exponential decay; the exponential decay constant within those 
regions was the apparent diffusion coefficient (ADC).
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Figure 1 – 14 Diffusion-weighted image (DWI) of whole mouse brain (sagittal view) (A). 
Diffusion-sensitizing gradients were applied perpendicular to page, producing images which 
clearly reveal the optic nerve (A, red arrow). Based on the result in (A), we adjusted another 
image plan that was perpendicular to the optic nerves. Then, we could obtain another two DWIs 
with gradient direction from left to right with two b values (B). The DWIs in (A) and (B, which 
was applied with higher b value) show that the surrounding CSF was suppressed and reflected 
optic nerve structure clearly. According to Stejskal-Tanner equation (Eq. (1.38)), we calculated 
ADC map (C) from two DWIs (B). The ADC of optic nerves were lower than other moues 
brain tissues suggests that applied gradient was perpendicular to optic nerves, and spins in the 
optic nerves didn’t have severe phase differences. Comparing to other mouse brain tissue, the 
signal intensity of optic nerves is considerably higher.   
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1.8 Magnetic Resonance Imaging (MRI) as a bio-marker to assess functional deficits 
 The discussion in the section 1.7.1 shows that MRI could reflect tissue contrast due to 
different T1 and T2 relaxation time. The first 2D MR image was introduced by Lauterbur [52]. 
In that paper, he used paramagnetic Mn
2+
 to show relaxation time could affect signal intensity. 
Therefore, Mn
2+
 was the first MRI contrast agent. Recently, manganese-enhanced MRI (MEMRI) 
has been widely used in animal studies, including mouse [53, 54, 11], rat [55-57], songbird [58], 
and monkey[59]. Manganese (Mn
2+
), a calcium (Ca
2+
) analog, enters cells through voltage-gated 
Ca
2+
 channels. After entry into the cell, Mn
2+
 is transported by fast axonal transport in vesicles 
and released into the synaptic cleft [54, 60]. Because Mn
2+
 is paramagnetic, it reduces T1 
relaxation in tissue water and produces concentration-dependent hyper-intensities in T1-
weighted (T1W) imaging [61] (Fig. 1 – 15). Therefore, Mn2+ can serve as both contrast agent 
and axonal transport tracer. Taking the visual system as an example, MEMRI provides a 
potential approach to track the pathway from retinal ganglion cell (inner layer of retina), optic 
nerve, to contralateral optic tract and superior colliculus. However, the cellular toxicity of Mn
2+
 
has long been recognized [61, 62]. In Chapter 2, we compared functional effects of topical 
loading or intravitreal injection with working dosage. Briefly, topical loading with higher 
concentration of MnCl2 damaged photoreceptor layers but not optic nerve. After optimizing 
working dosage, we applied MEMRI to EAE mice with optic neuritis to compare differences in 
axonal transport rates. We found that at the onset of optic neuritis in EAE mice, a significantly 
decreased axonal transport rate was observable (detailed in Chapter 3).   
 In section 1.7.2, we mentioned that ADC from diffusion MRI measurement can reflect 
the tissue structures or geometric orientation. We further proposed that ADC is a potential means 
to directly reveal axonal activity. Le Bihan et al. have reported that in human visual cortex, 
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signal intensity increased (ADC decreased) in diffusion-weighted image (DWI) during visual 
stimulation [63]. However, Miller et al. reported that such signal/ADC change in human visual 
cortex might result from a vascular contribution [64]. In white matter, blood oxygen level 
dependent (BOLD) fMRI is not easy to perform due to less blood flow and blood volume [65]. 
Therefore, in Chapter 4, we introduced our recent finding that during visual stimulation, 
decreased ADC in mouse optic nerve (gradient direction was perpendicular to optic nerve) was 
observed and excluded vascular contribution as well. Such ADC change might be related to 
extracellular space shrinkage due to stimulation-associated change in size or shape of glial cells 
or osmotic water shift across membrane. In Chapter 5, we further applied diffusion fMRI to EAE 
mice with optic neuritis. Then, we compared ADC change of EAE and sham mice during visual 
stimulation. The results showed that activation-associated ADC change of EAE mice was less 
than sham mice.  
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Figure 1 – 15 The T1 relaxation curves of mouse optic nerve with and without Mn2+ loading at a 
4.7 T animal scanner with multiple TR (from 200 ms to 10 s, figure only showed TR from 0 to 
6.5 s) and minimal TE using stand spin-echo sequence (A). The measurement was performed one 
day after intravitreal Mn
2+
 injection with 0.25μL of 0.2 M MnCl2 (A). Open symbols are 
experimental data and solid lines are fitting curves, and T1 of Mn
2+
-loading and normal mouse 
optic nerve is ~1.1 and 1.5 s, respectively. Since Mn
2+
 reduces T1 relaxation time in tissue water, 
Mn
2+
-loading mouse optic nerve shows hyper-intensities in T1-weighted image (B, left optic 
nerve). 
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Chapter 2 
Manganese-Enhanced MRI (MEMRI) via Topical Loading of Mn
2+
 
Significantly Impairs Mouse Visual Acuity: A Comparison with Intravitreal 
Injection 
This chapter represents the latest version of a manuscript that is targeted for submission to NMR 
in Biomedicine. 
(Tsen-Hsuan Lin, Chia-Wen Chiang, Kathryn Trinkaus, William M. Spees, Peng Sun, and 
Sheng-Kwei Song) 
 
Abstract 
Purpose Manganese enhanced MRI (MEMRI) with topical loading of MnCl2 provides 
comparable optic nerve enhancement as seen by intravitreal injection. However, the impact of 
this novel and noninvasive Mn
2+
 loading method on visual function remains undefined. The 
objective of this study is to determine the optimal topical Mn
2+
 loading dosage for MEMRI and 
to assess visual function after MnCl2 loading. Intravitreal administration was performed to 
compare the two approaches of MnCl2 loading. 
Methods Twenty-four hours after topical loading of 0, 0.5, 0.75, and 1M MnCl2, T1-weighted 
(T1W), T2-weighted (T2W), diffusion tensor image (DTI) and visual acuity were performed to 
determine the best topical loading dosage for MEMRI measurements and to assess the integrity 
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of retina and optic nerves. Mice were perfusion fixed immediately after in vivo experiments for 
H&E and immunohistochemistry staining. 
Results Topical loading of 1 M MnCl2 damaged the retinal photoreceptor layer with no 
detectable damage to optic nerves. For the topical loading, 0.75-M MnCl2 was required to see 
sufficient enhancement of optic nerve. At this concentration the visual function was significantly 
affected followed by a slow recovery. Intravitreal injection (0.25 µL of 0.2 M MnCl2) slightly 
affected visual acuity with full recovery a day later.  
Conclusion Intravitreal Mn
2+
 injection provides more reproducible results with less adverse side 
effects than topical loading.   
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2.1 Introduction 
Manganese (Mn
2+
), as a calcium (Ca
2+
) analog, enters cell bodies through voltage-gated 
Ca
2+
 channels. After entry into the cell, Mn
2+
 is transported by fast axonal transport in vesicles 
and released into the synaptic cleft [1].  Mn
2+
 produces a concentration-dependent shortening of 
tissue T1 due to its paramagnetic property. Therefore, Mn
2+
 can serve as both contrast agent and 
axonal transport tracer. T1-weighted (T1W) imaging is usually performed to monitor real-time 
Mn
2+
 transport reflected by the extent of enhancement in T1W MRI [2]. Therefore, MEMRI 
provides a potential approach to further explore the visual pathway from retinal ganglion cells, 
optic nerve, to contralateral optic tract and superior colliculus [3]. Indeed, manganese-enhanced 
MRI (MEMRI) has recently been used to investigate optic nerve axonal integrity [4-7], retinal 
projections to the superior colliculus through intravitreal injection of MnCl2 [8], or layer-specific 
calcium-dependent retinal fMRI activation [9, 10]. 
The cellular toxicity of Mn
2+
 has long been recognized as overexposure causes 
Parkinsonism [11]. Therefore, it is important to determine optimal Mn
2+
 dosing, which is a 
tradeoff between maximizing MR detectability and minimizing toxicity [12]. The toxicity of 
MnCl2 after intravitreal injection has been examined previously by histology and visual function 
measurements [13-15, 7, 16]. In an attempt to remedy the invasive intraocular injection of MnCl2, 
Sun et al. proposed to deliver Mn
2+
 through topical loading [17]. Topical loading is a simple, 
noninvasive approach for Mn
2+
 delivery, achieved by dropping MnCl2 solution directly onto the 
eye.  The effect of repetitive topical MnCl2 loading was recently examined reporting RGC loss 
after three bi-weekly applications of 1 M MnCl2 while no RGC loss was observed after three 
monthly applications [18]. Corneal thickening was also observed after seven bi-weekly 
applications [18]. It appeared that increasing the time interval between repetitive topical 
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applications reduced adverse effects seen in RGC and cornea. In this study, the effect of topical 
and intravitreal loading of MnCl2 was examined by assessing post-loading visual acuity and 
structural integrity of both retina (by high resolution in vivo T2-weighted MRI and histology) 
and optic nerves ( by in vivo diffusion tensor imaging, i.e., DTI). Results suggest that intravitreal 
injection of MnCl2 is safe with limited adverse effects when administered in small volume and 
low doses, sufficient to monitor axonal transport. 
 
2.2 Materials and Methods 
All experimental procedures were approved by Washington University’s Animal Studies 
Committee and conformed to the NIH Policy on Responsibility for Care and Use of Animals and 
the ARVO Statement for the Use Animals in Ophthalmic and Vision Research.  
2.2.1 Topical MnCl2 Loading 
Thirty-five female C57BL/6 mice obtained from Jackson Laboratory (Bar Harbor, ME) at 
8 weeks of age underwent topical loading of 0 (n=5), 0.5 (n=5), 0.75 (n=15), or 1 M (n=10) of 
MnCl2 in 0.9% saline. After anesthetized using 1.5-2% isoflurane/oxygen, a 30-µL drop of 
MnCl2 was introduced covering the entire right eye. An additional 10µL of MnCl2 was applied 
every 15 min to maintain the topical-fluid volume, different from the original procedure by Sun 
et al.[17], assuring a consistent loading among various lab personnel. 
2.2.2 Intravitreal MnCl2 Injection 
An additional twenty 8-week old female C57BL/6 mice were employed to compare the 
“safe” injection volumes of 0.25 and 2 µL using saline (n=5 each group), and the “safe” dose 
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using 0.25 (n=5) and 0.125 (n=5) µL of 0.2-M MnCl2 in saline. Mice, under 1.5-2% 
isoflurane/oxygen anesthesia, were placed on a custom-made head holder for intravitreal 
injection at 3-µL/min using a 34-gauge needle connected to a micro-injection pump (WPI 
Instrument, FL). After infusion, the needle was left in place for an extra 1 minute before 
withdrawal. A drop of topical antibiotic was applied after removing the injection needle [19]. 
2.2.3 Visual Acuity Assessment 
Visual acuity (VA) was assessed using the OptoMotry Virtual Optometry System, 
(CerebralMechanics, Inc., Canada). Mice were placed on the platform inside the chamber with 
virtual rotating columns projected on four LCD monitors surrounding it. The spatial frequency in 
cycle/degree (c/d) starting from 0.1 c/d was incremented in steps of 0.05 c/d until the mouse 
stopped responding to the projected visual patterns, which was recorded as the VA [20, 21].  
Thirty normal C57BL/6 mice were measured to establish the baseline VA for naïve animals. VA 
was measured before MnCl2 loading and at days 1 through 7 after topical MnCl2 loading, and at 
4, 24, and 48 hours after intravitreal injection.    
2.2.4 MRI: DTI and T1-weighted imaging of the visual pathway  
Twenty-four hours after topical or intravitreal MnCl2 loading, MRI measurements were 
performed on a 4.7T Agilent DiectDrive small-animal MRI system (Agilent Technologies, CA) 
equipped with a Magnex/Agilent HD gradient coil set (Magnex, Oxford, UK) with pulse gradient 
strength up to 58 G/cm and a gradient rise time ≤ 295 µs. Mice were anesthetized by 
isoflurane/oxygen (1.5%). Respiratory rate and body temperature were monitored during 
experiments using a MR compatible animal monitoring system (SA Instrument, Inc., NY). The 
body temperature was maintained at 37C with a regulated circulating warm water pad placed 
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underneath mouse body along with regulated warm air blown into the magnet bore. An actively-
decoupled 1.7-cm receive coil was placed on top of the mouse head. The animal holder assembly, 
including the receive coil was placed in an 8-cm active-decoupled volume transmit coil [22, 23].  
2.2.4.1 T1-weighted Imaging 
A 3D gradient echo sequence was employed to image mouse brain with the following 
parameters: TR= 15 ms, TE= 2.63 ms, flip angle 20
º
, number of averages 16, FOV 15×15×22 
mm
3
, data matrix size 128×128×64 (zero-filled to 256×256×128). Regions of interest (ROI) were 
manually outlined according to a previously published protocol[17] on the extracted 2D images 
containing retina, optic nerve, and superior colliculus using ImageJ software (NIH, 
http://bigwww.epfl.ch/sage/soft/watershed/, US). The ROI of the Mn
2+
-loaded structures along 
the visual pathway was outlined and mean signal intensity was obtained using ImageJ. The 
signal intensity of the loaded ROI was normalized by the contralateral mean intensity to correct 
scan-to-scan sensitivity differences resulting from variable sample loading. 
 
2.2.4.2 DTI of Optic Nerve 
Optic nerve DTI was performed using a multi-echo spin-echo diffusion weighted imaging 
sequence (Tu et al., 2010) with the following parameters: TR=1.5 s, TE=34 ms (first echo time, 
including required time for diffusion-weighting gradients), inter-echo delay time 19 ms, FOV 
22.5×22.5 mm
2
, matrix size 192×192 (zero-filled to 384×384); in-plane resolution 117×117 mm
2
 
(prior to zero-filling), slice thickness 0.5 mm, two diffusion-sensitizing factors (b value) 0.0 and 
1.0 ms/µm
2
 (with δ = 5 ms and Δ = 18 ms). The standard six-direction diffusion encoding 
scheme was used, with [Gx, Gy, Gz] = [1, 1, 0], [1, 0, 1], [0, 1, 1], [-1, 1, 0], [0, -1, 1], and [1, 0, -
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1]. The image plane was adjusted to be as nearly perpendicular to optic nerve as possible to 
minimize partial volume effects. Fractional anisotropy (FA), axial (||) and radial () diffusivity 
maps were generated from the image data by programs written in Matlab (MathWorks, Natick, 
MA).  
2.2.5 T2-weighted Imaging of Retina 
For retinal imaging, mice were anesthetized by intraperitoneal injection of ketamine (87 
mg/kg) and xylazine (13 mg/kg) followed by constant subcutaneous infusion of ketamine (54 
mg/kg/h)/xylazine (4 mg/kg/h). The infusion rate was adjusted to maintain the respiratory rate 
between 150 - 210 breaths/min during imaging. Retina imaging was performed on an Agilent 
11.74 T DirectDrive small-animal MRI system using a spin-echo sequence with the following 
parameters: TR = 2 s, TE = 34 ms, FOV 12×12 mm
2
, matrix size 256×256 (zero-filled to 
512×512); in-plane resolution 47×47 µm
2
 (prior to zero-filling), slice thickness 0.4 mm. All 
images were acquired on a nasal-temporal slice bisecting the eye through the retina and optic 
nerve head.   
2.2.6 Histology  
2.2.6.1 Optic nerve  
Following MR experiments, mice were perfused with 4 % paraformaldehyde in 
phosphate-buffered saline (PBS). Brains were excised and post-fixed in fixative for 24 hours 
then transferred to 1% PBS for storage at 4
º
C until histological analysis. Mouse optic nerves 
were embedded in 2 % agar gel followed by paraffin embedding [24]. Five-µm thick transverse 
slices were sectioned for immunohistochemical staining. All sectioned tissues were 
deparaffinized, rehydrated, and blocked in solution mixed with 1% bovine serum albumin (BSA) 
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and 2% Triton-X100 for an hour at room temperature to prevent non-specific binding and to 
increase antibody permeability. Slides were incubated in monoclonal anti-phosphorylated 
neurofilament antibody (SMI-31; 1:2000, Covance) to stain non-injured axons, or in rabbit anti-
myelin basic protein (MBP) antibody (1:1000 Sigma-Aldrich, MO) to stain myelin sheath at 4
º
C 
overnight. After rinsing, goat anti-mouse IgG or goat anti-rabbit IgG conjugated Alexa 488 
(1:800, Invitrogen, CA) were applied to visualize immunoreactivity of phosphorylated 
neurofilaments and MBP.  Finally, slides were covered using Vectashield Mounting Medium 
with 4´,6-diamidino-2-phenylindole (DAPI) (Vector Laboratory, Inc., Burlingame, CA). 
Histological slides were examined with Nikon Eclipse 80i fluorescence microscope. Images were 
captured with a black-and-white CCD camera using MetaMorph software (Universal Imaging 
Corporation, Sunnyvale, CA). 
2.2.6.2 Retina  
Mouse eyes were flash-frozen immediately after enucleation to avoid dehydration and 
fixation induced tissue distortion. Frozen-cut 8-µm-thick tissue sections were stained with 
hematoxylin and eosin (H&E) to assess the integrity of multiple retinal layers. Histological slices 
were scanned with Olympus NanoZoomer slide scanner (Hamamatsu Photonics, Hamamatsu, 
Japan). For quantitative analysis of H&E staining, scanned images were exported with NDP 
viewer software (Hamamatsu Photonics, Hamamatsu, Japan) with 20× objective. ROIs were 
selected to contain the retina segment with proximal and distal ends located at 250 and 800 µm 
away from the optic nerve head on both sides of the nerve head [25]. Within the ROIs, the retinal 
thickness was measured from nerve fiber layer to retina pigment epithelium every 55 µm (i.e., 10 
measurements total). Ten measurements were averaged as the representative thickness for that 
side of retina.  
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2.2.6.3 Statistical analysis 
Multiple comparisons for T1W enhancement in retina, optic nerve, and superior 
colliculus after Mn
2+
 loading were performed using a linear repeated measures model with 
adjustment for multiple testing using Tukey's HSD (honest significant difference). A linear 
repeated measures model was used to estimate the mean difference in VA between loaded and 
contralateral control eyes by dosages and day of experiment (from baseline to day 7 ). The effect 
of Mn
2+
 loading on the mean retinal thickness was assessed using a linear model on a log scale in 
each of the five study groups. Each Mn
2+
 treated group was compared with the saline control. P-
values for the difference in mean retinal thickness were adjusted for multiple tests using Tukey’s 
HSD. 
 
2.3 Results 
2.3.1 Topical MnCl2 Loading 
2.3.1.1 Manganese Enhanced T1W MRI 
T1-weighted  images of 1-M MnCl2 loaded visual pathway including ipsilateral retina 
and optic nerve (ON), and contralateral lateral geniculate nucleus (LGN) and superior colliculus 
(SC) clearly demonstrated signal enhancement on these structures (Fig. 2 – 1A). The image of 
retina and optic nerve with 0.5, 0.75, and 1 M of MnCl2 loading (Fig. 2 – 1B) suggested that both 
1 and 0.75 M of MnCl2 loading led to discernible signal enhancement in optic nerve while 0.5 M 
did not. Compared to the saline group, the group-averaged ROI analysis (Fig. 2 – 1C) 
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demonstrated that 0.75 and 1 M of MnCl2 loading significantly enhanced all structures along the 
visual pathway.  
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Figure 2 – 1 Representative T1W images acquired from a mouse brain at 24 hours after topical 
MnCl2 loading (A), ipsilateral retina and optic nerve (ON), and contralateral lateral geniculate 
nucleus (LGN) and superior colliculus (SC) are enhanced with topical loading (arrows). The 
oblique images (B) bisecting retina and optic nerve after topical loading of 1, 0.75, and 0.5M 
MnCl2 suggest that 0.75M MnCl2 was sufficient to produce discernible enhancement of optic 
nerve. Bar graphs (C) demonstrate the signal intensity ratio between labeled and control retina, 
ON, and SC. With 1 and 0.75M MnCl2 loading, a significant enhancement of the structures along 
the visual system (retina, ON, LGN, SC) was clearly seen. In contrast, only slight retinal 
enhancement was seen with 0.5M MnCl2 loading. Therefore, 0.75M was the concentration 
selected for topical loading in this study. 
* indicates that P < 0.005 compared to saline group via Tukey HSD test. 
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2.3.1.2 Visual Acuity  
The VA of normal female C57BL/6 mice is 0.37 ± 0.03 c/d (mean ± SD; n=30). Topical 
loading of 1-M MnCl2 caused total blindness (VA ~ 0 c/d) at one day after loading without 
recovery up to 7 days after loading (open squares; Fig. 2 – 2). A significant VA decrease in eyes 
following 0.75-M MnCl2 loading was also observed (open circles; Fig. 2 – 2). However, the 
decreased VA gradually recovered to the normal range at day 5 (VA ≥ 0.3 c/d). Contralateral 
control eyes in animals treated without 1 and 0.75-M MnCl2 loading were not affected 
throughout the time course (filled symbols, Fig. 2 – 2). Mice topically loaded with 0.5M MnCl2 
exhibited a slight VA decrease at one day after loading and recovered to normal at day 2; saline-
loaded eyes exhibited normal VA throughout the time course (data not shown).     
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Figure 2 – 2 Visual acuity was measured daily in eyes after topical loading with 0.75 and 1M 
MnCl2 (open symbols), and in contralateral, control eyes (filled symbols). Tests for difference 
between the dose groups indicate that there is no difference at baseline or on the first day of 
treatment. Between days 2 and 7, however, the difference between loaded and control eyes is not 
the same in the two different dosage groups (p-values < 0.0001 at days 2-7). At one day after 1M 
of MnCl2 loading, the visual acuity decreased to zero (completely blind) and did not recover 
throughout the 7-day time course. In contrast, one day after 0.75M of MnCl2 loading visual 
acuity decreased to 0.1c/d and recovered beginning on Day 2 (p < 0.05, compared to 1M loading 
eyes) until recovering back to the normal range by Day 6. 
Note 1: mean VA of normal B6 mice (n=30) is 0.36 ± 0.03 (c/d; mean ± SD) 
Note 2: c/d denotes units of cycles per degree 
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2.3.1.3 DTI and Immunohistochemistry of Optic Nerve  
In vivo DTI of optic nerves was performed at days 1 and 7 after 1M MnCl2 loading (VA 
= 0 c/d). Color-coded FA, maps derived from DTI analysis clearly delineated the optic nerves 
(Fig. 2 – 3A). There was no statistically-significant difference in group-averaged || and  
between the loaded and control optic nerves at days 1 and 7 after MnCl2 loading (Fig. 2 – 3B). 
These DTI findings suggested that there was no detectable axon or myelin injury after topical 
MnCl2 loading [26], supported by the immunohistochemical staining of phosphorylated 
neurofilaments (SMI-31; green dots in Fig. 2 – 3C) and myelin basic protein (MBP; red rings in 
Fig. 2 – 3C) from the same nerves after in vivo DTI. 
  
54 
 
 
 
 
 
 
 
 
 
  
55 
 
Figure 2 – 3 Brain DTI maps, containing optic nerves, from mice at one and seven days after 
topical loading of 1M MnCl2 were examined to assess the effect of Mn
2+
 on axonal integrity. The 
region-of-interest (ROI) based analysis was performed on diffusion metrics, including fractional 
anisotropy (FA), axial (||), and radial () diffusivity, from each optic nerve (A, outline in red). 
At one and seven days after 1M of MnCl2 loading, there was no difference in ||  and  between 
the optic nerves from the control (B, black bars) and loaded (white bars) eyes suggesting no axon 
or myelin injury upon Mn
2+
 loading. The matched immunohistochemical staining of 
phosphorylated neurofilament (SMI-31) and myelin basic protein (MBP) strongly support the 
axonal and myelin sheath integrity seen by in-vivo DTI (C).  
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2.3.1.4 T2W Images and H&E Staining of Retina  
T2W images acquired from retinas in control and topical-loading mice at day 7 after 1M 
MnCl2 loading revealed the previously reported dark-bright-dark layer contrast of the control 
retinas [27, 28] (Fig. 2 – 4A and 2 – 4B). Significant thinning of the retina was seen in the 1M 
MnCl2 loaded eyes (Fig. 2 – 4C and 2 – 4D).  Retinal layers examined by H&E staining showed 
significant cell swelling (~26 % increased thickness) at day 1 (VA = 0 c/d; the time point of best 
T1W enhancement) and significant retinal thinning (~31 %)  at day 7 (VA = 0 c/d) after 1M 
MnCl2 loading (Fig. 2 – 4E and 2 – 4F). A slight swelling of the retina was seen at day 1 after 
0.75M MnCl2 loading with recovery to the normal thickness at day 5 (VA ≥ 0.3 c/d). Retina with 
saline loading exhibited the same thickness as that reported in the literature for normal mice (Fig. 
2 – 4E and 2 – 4F) [25, 19].   
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Figure 2 – 4 In-vivo T2-weighted (T2W) imaging was performed to compare the retinal 
thickness between the saline (sham) (A) and MnCl2-loaded (B) eyes. Zoom-in images of mouse 
retina (C and D) seven days after topical loading of 1M of MnCl2 exhibit typical T2W MRI 
features of a mouse retina wherein sclera appears dark (white stars), choroid is bright (black 
arrows), and retinal layers (white double-headed arrows) exhibit intensities between sclera and 
choroid. Clear thinning in Mn
2+
 loaded retina was seen 7 days after topical loading in T2W MRI. 
The hematoxylin and eosin (H&E) staining of the frozen-embedded retina confirmed the MRI 
detected retinal thinning (E). At 24 hours after 1 M MnCl2 loading, heterogeneous retinal 
swelling was observed. On day 7 after 1M MnCl2 loading, photoreceptor layers degeneration 
was visible. 0.75 M MnCl2 loading caused retina slightly swelling at day 1 but recovery at day 5 
(E).  To quantify the extent of retinal thickness change, H&E images were analyzed (F). A linear 
model was used to estimate mean retinal thickness on a log scale in each of the 5 study groups. 
Each of the MnCl2 treated groups was compared with the saline control. P-values for the 
difference in mean retinal thickness are adjusted for multiple testing using Tukey's HSD test. 
One day after 1M MnCl2 loading, transient significant swelling of retina (p < 0.005, with 
blindness) was seen followed by significant retinal thinning at Day 7 (p < 0.005, with no 
recovery of visual function). At 0.75M of MnCl2 loading, mild retinal swelling was seen at 1 day 
(significantly-decreased VA without blindness), which returned to normal thickness 7 days after 
loading (visual acuity returned to normal by 5-6 days post-loading). 
Diamond symbols: mean value 
Scale bar: 100 µm  
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2.3.2 Effect of Intravitreal Injection  
2.3.2.1 Volume Effect 
There was no change in VA of eyes receiving intravitreal 0.25-µL saline injection (Fig. 2 
– 5A). In contrast, VA impairment was seen in eyes at 4 and 24 hours after intravitreal 2-µL 
saline injection, which recovered at 48 hours (Fig. 2 – 5A).  Histological examinations revealed 
significant retinal swelling (~17% increase in thickness) at 24 hours after 2µL-saline injection 
while no detectable difference was seen in eyes with 0.25-µL saline injection or topical saline 
loading (Fig. 2 – 5C and 2 – 5D).  
2.3.2.2 Dose Effect 
Sufficient T1W enhancement in the visual pathway was seen 24 hours after intravitreal 
injection of 0.25-µL 0.2-M (50 nmol) MnCl2 (Fig. 2 – 5B) as previously reported [13]. In 
contrast, we failed to see a detectable T1W enhancement in the visual pathway using the other 
reported dosage [13], 0.125-µL 0.2-M MnCl2, (25 nmol; data not shown). In the 50 nmol dosage 
group, histological analysis of retina using H&E staining showed slight cell swelling at 4 hours, 
which recovered at 24 hours post-injection (Fig. 2 – 5C and 2 – 5D). 
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Figure 2 – 5 The effect of intravitreal Mn2+ injection on retinal integrity and visual function was 
examined on mouse eyes receiving 0.25 and 2 µL saline injection. The effect of injecting 0.25 
and 2 µL on the visual acuity (VA) was examined where 2µL saline injection transiently 
impaired visual function at 4 hours and Day1 after injection, subsequently recovered (VA ≥ 0.3) 
at Day 2 (A). The injection of 0.25µL of saline did not impact VA (A). Representative T1W 
images (B) obtained at 24 hours post-injection with the working dosage (0.25µL and 0.2M 
MnCl2, 50 nmol) demonstrate the effect of Mn
2+
- induced intensity enhancement in the loaded 
visual pathway (left retina, left optic nerve, right LGN, and right SC). The VA was affected by 
the working dosage at 4 hours post-injection with nearly full recovery by 24 hours post-injection 
(A). Retinal thickness was examined with H&E staining of frozen-embedded mouse eyes (C and 
D). The previously reported safe intravitreal 2 µL saline injection caused retinal swelling at Day 
2. In contrast, the other reported safe intravitreal saline injection (0.25 µL) indeed did not cause 
any retinal swelling of the injected eyes (C and D). MnCl2 injection caused slight retinal swelling 
at 4 hours that recovered at 24 hours post-injection. Histologically-revealed retinal thickening 
paralleled the decreased VA caused by injection volume and Mn
2+ 
(A). 
Diamond symbols: mean value 
Scale bar: 100 µm 
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2.4 Discussion 
This study investigated the toxicity of noninvasive topical Mn
2+
 loading using functional 
(VA) and structural (MR) measurements followed by histological validation. Our findings show 
that topical MnCl2 loading caused photoreceptor layers degeneration without detectable damage 
to the optic nerve within the 7-day timecourse of this investigation. In addition, we also 
investigated the impact of literature-reported safe dose of intravitreal MnCl2 injection concluding 
that intravitreal injection causes insignificant visual impairment and is probably safer for 
MEMRI studies than the newly proposed topical loading. 
2.4.1 Topical loading 
The route of Mn
2+
 entry is believed to start from the conjunctiva passing through the 
ciliary body [29, 30]. Afterwards, Mn
2+
 may diffuse into the choroid vasculature passing through 
the blood-retinal barrier [31] to enter the retinal layers.  In addition, Mn
2+ 
may also pass through 
blood-aqueous barrier diffusing into vitreous space reaching the retina ganglion cell layer [32, 
29]. In our hands, topical loading only resulted in anterior chamber and retina enhancement 
while the vitreous space was not enhanced. This is consistent with findings by Sun et al. 
reporting no intravitreal enhancement [17]. Although a definitive conclusion may not be 
established from the current study, the observed lack of vitreous enhancement as well as the 
preferential photoreceptor layer injury after topical loading suggests that Mn
2+
 may enter the 
ocular space primarily through non-corneal permeation across the conjunctiva and sclera into the 
anterior uvea.   
Visual acuity (VA) reflects the visual function and ocular integrity of retinal efferent 
pathways to subcortical visual structures [21]. In the present study, VA was employed to assess 
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the effect of Mn
2+
 loading since VA of normal mice has been measured consistently [20]. Our 
VA measurements from thirty female C57BL/6 mice were in agreement with Prusky’s finding 
with less than 10% co-variance (0.37 ± 0.03 c/d; mean ± SD; n = 30).  The acute 73% decrease 
in VA after 0.75 M MnCl2 loading followed by a slow recovery and the total loss of vision after 
1 M MnCl2 loading without recovery (throughout the course of experiment) suggests that topical 
loading adversely affects visual function of the loaded eye as a result of Mn
2+
 toxicity since there 
was no VA change after topical saline loading. 
With 1M MnCl2 topical loading, the retina thickened at 1 day followed by significant 
thinning at 7 days after loading [(~31%, p < 0.005); Fig. 2 – 4E and 2 – 4F]. Retinal thickening 
at 24 hours after 1M MnCl2 loading appears to result from cell swelling [33, 19], while 
subsequently decreased retinal thickness is likely the result of may be related to retinal 
degeneration and tissue loss.   There was a negligible retinal thickness change by 0.75M topical 
loading (Fig. 2 – 4F). The increased image intensity of choroid (Fig. 2 – 4D) probably resulted 
from manganese accumulation in endothelial cells [34]. 
Photoreceptor layer degeneration was seen in H & E staining (Fig. 2 – 4E), suggesting 
that the entry of excess calcium analog, Mn
2+
, could cause metabolic dysfunction and eventual 
photoreceptor cell loss [14]. At day 1 with 1-M MnCl2 loading, retina thickened variably (Fig. 2 
– 4E) due to differential uptake of topically loaded Mn2+ between mice. Our T2W images 
exhibited strong vitreous signal intensities (Fig. 2 – 3A ~ 2 – 3D), potentially confounding layer 
thickness estimation although retinal swelling and thinning was clearly visible in T2W images. A 
balanced steady state free precession (bSSFP) MR sequence has been demonstrated to be time-
efficient to detect retinal layer and layer-specific responses to hypoxia in retinal and choroidal 
vasculature, which are separated by an avascular region [35]. This approach could be used to 
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overcome the shortcoming of T2W measurement employed herein to better assess retinal 
thickness. The optic nerve integrity was examined using in vivo DTI followed by 
immunohistochemistry (Fig. 2 – 3B and 2 – 3C). Normal axial (||) and radial () diffusivities 
after MnCl2 loading suggest axonal integrity of the loaded optic nerve [26]. Postmortem 
immunohistochemistry findings supported the conclusions drawn from in vivo DTI 
measurements. There was no detectable injury in either RGC layer (Fig. 2 – 4E) or optic nerve 
(Fig. 2 – 3B and 2 – 3C). The visual function impairment is more pronounced with increasing 
retinal morphological distortions—initially retinal swelling (Fig. 2 – 2, 2 – 4E and 2 – 4F) and 
subsequently photoreceptor loss and thinning of the retina. Topical saline loading did not cause 
retinal thickness change, or VA impairment.  The results suggest that Mn
2+
 was the primary 
cause of the decreased VA and reduced retinal thickness. 
2.4.2 Intravitreal injection 
Intravitreal injection of MnCl2 is a common practice for MEMRI studies.  Published 
reports have examined toxicity of intravitreal injection of MnCl2 in mice and rats [13-15, 36].  
Bearer et al. used visual evoke potential (VEP) to assess visual function [13] reporting that 0.5µL 
of saline injection affected VEP response. They suggested a 0.25µL injection of 200mM MnCl2 
(equivalent of 50 nmol) to be the safe dose for MEMRI studies in C57BL/6 mice. Haenold et al. 
measured VA to determine visual function suggesting that 2µL of 0.0075M MnCl2 (equal to 15 
nmol) as the safe dose for the same mouse strain [14]. They found that 50 nmol caused 
photoreceptor degeneration with RGC injury observed at a dose over 50 nmol.  
The volume of the vitreous space in C57BL/6 mice is approximately 5 µL.  Chen et al. 
have previously reported that 0.5 µL of intravitreal saline injection was safe [19]. Haenold et al. 
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reported normal VA two days after 2 µL of saline injection [14]. The current finding saw 
transient impairment of VA with 2 µL of saline injection (Fig. 2 – 5A). The recovery of VA 2 
days after injecting 2 µL of saline was in agreement with that seen by Haenold et al. A 
significant retinal swelling was observed with 2 µL saline injection in the present study (Fig. 2 – 
5C and 2 – 5D) while 0.25µL saline injection did not impact VA (Fig. 2 – 5A) or retinal 
thickness (Fig. 2 – 5C and 2 – 5D) at any time point. Our findings support the conclusion of 
Bearer et al. suggesting the optimum dose for intravitreal injection is 0.25 µL of 200 mM MnCl2. 
We failed to see enhancement using the dose proposed by Bearer et al., 0.125 µL of 200 mM 
MnCl2 (data not shown). 
In conclusion, we found that both topical loading and intravitreal injection of MnCl2 
provided similar T1W enhancement in the visual system for assessing anterograde axonal 
transport. Despite the non-invasive nature of MnCl2 loading, topical loading significantly 
impaired VA. The photoreceptor layer was significantly injured with retinal ganglion cells 
largely unaffected thus no detectable injury in the optic nerve.  The working concentration of 
0.75 M MnCl2 offers sufficient enhancement for assessing axonal transport. However, the visual 
function was still affected at this dose thus cautioning functional correlation studies using topical 
loading.  In contrast, the previously reported safe dose for intravitreal injection proposed by 
Bearer et al. is ideal for axonal transport correlating with functional assessment in mouse visual 
system.   
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Chapter 3 
Axonal transport rate decreased at the onset of optic neuritis in EAE mice 
This chapter represents a manuscript initially submitted on August 16th to The Journal of 
Neuroscience and currently under review.  
(Tsen-Hsuan Lin, Joong Hee Kim, Carlos Perez-Torres, Chia-Wen Chiang, Kathryn Trinkaus,  
Anne H. Cross, and Sheng-Kwei Song)
 
Abstract 
 Optic neuritis is frequently the first symptom of multiple sclerosis (MS), an inflammatory 
demyelinating neurodegenerative disease. Impaired axonal transport has been considered as an 
early event of neurodegenerative diseases. However, few studies have assessed the integrity of 
axonal transport in MS or its animal models. In this study, we employed manganese-enhanced 
MRI (MEMRI) to assess axonal transport in optic nerves in experimental autoimmune 
encephalomyelitis (EAE) mice, at the onset of optic neuritis. Axonal transport was assessed as (a) 
optic nerve Mn
2+
 accumulation rate (in % signal change/hour) by measuring the rate of increased 
total optic nerve signal enhancement, and (b) Mn
2+
 transport rate (in mm/hour) by measuring the 
rate of change in optic nerve length enhanced by Mn
2+
. Compared to sham-treated healthy mice, 
Mn
2+
 accumulation rate was significantly decreased by 19% and 38% for EAE mice with 
moderate and severe optic neuritis, respectively. The axonal transport rate of Mn
2+
 was 
significantly decreased by 43% and 65% for EAE mice with moderate and severe optic neuritis, 
respectively. The degree of axonal transport deficit correlated with the extent of impaired visual 
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function, as well as the severity of inflammation, demyelination, and axonal injury at the onset of 
optic neuritis.   
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3.1 Introduction 
Multiple sclerosis (MS) is an inflammatory demyelinating disorder of the central nervous 
system (CNS) causing significant neurological dysfunction that accumulates over a lifetime[1]. 
Experimental autoimmune encephalomyelitis (EAE) is a widely used animal model of MS 
exhibiting many MS-like neurological dysfunctions including optic neuritis (ON) [2, 3], which is 
often an early symptom of MS [4-7].  Inflammatory demyelination and axonal injury in the optic 
nerve that are commonly seen in MS patients are also frequently present in EAE-affected mice 
(EAE mice) [8-10]. Accumulation of amyloid precursor protein (APP) is regarded as an early 
marker of axonal injury in MS patients and EAE mice [11-16]. Interruption of axonal transport in 
injured axons results in the accumulation of APP, which can be detected by 
immunohistochemistry (IHC) [11, 17]. Hence, axonal transport disruption is believed to be an 
early event in EAE and in some patients with MS.  
Magnetic resonance imaging (MRI) has played crucial roles in examining pathologies of 
the optic nerve in rodent EAE [18-21]. Diffusion tensor imaging (DTI) can specifically reflect 
pathologies of axon injury and demyelination in optic nerve [8, 22, 23]. Visual function tests to 
assess optic nerve integrity are readily available in both human and animal models [23-25]. Thus, 
the optic nerve provides an ideal system to investigate the interrelationship between white-matter 
pathologies and functional outcomes. Manganese-enhanced MRI (MEMRI) has been applied in 
the rodent CNS [26-30] to investigate ion homeostasis and axonal transport. Manganese ion 
(Mn
2+
), as a calcium analogue, is taken up by neurons through voltage-gated Ca
2+
 channels. In 
the mouse visual system, Mn
2+ 
is taken up by retinal ganglion cells, packaged in vesicles, and 
transported along microtubules down the axonal tract [31]. Mn
2+
, a paramagnetic ion, reduces 
tissue water T1 relaxation time and its presence in tissues can be identified as hyper-intensities in 
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the T1W image [32]. Therefore, Mn
2+
 can serve as both a contrast agent and an axonal transport 
tracer. 
In this study, MnCl2 was injected in the vitreous of sham and EAE mouse eyes 
immediately followed by serial 3D-T1W images for 5.5 hours to quantify the axonal transport 
rate. Our results suggest that axonal transport impairment is present at the onset of optic neuritis 
in EAE mice, and correlates with impaired visual function and the underlying pathologies.  
 
3.2 Materials and Methods 
All experimental procedures involving animals were approved by Washington 
University’s Animal Studies Committee and conformed to the Public Health Service Policy on 
Humane Care and Use of Laboratory Animals (http://grants.nih.gov/grants/olaw/olaw.htm). 
3.2.1 Experimental autoimmune encephalomyelitis (EAE)  
Sixteen 7-week old C57BL/6 mice were obtained from Jackson Laboratory (Bar Harbor, 
ME). Before immunization, mice were housed with 12-hour dark/light cycle for a week. Ten 
mice were randomly selected to be immunized with 50 µg MOG35-55 peptide emulsified (1:1) in 
incomplete Freund’s adjuvant (IFA) and Mycobacterium tuberculosis. Pertussis toxin (300 ng; 
PTX, List Laboratories, Campbell, CA) was injected intravenously on the day of MOG35-55 
immunization and two days later. The remaining six sham mice underwent the same 
immunization procedure with only IFA without MOG35-55. Mice were assessed daily for 
neurological disabilities using a standard clinical score [33] system: 1 = limp tail; 2 = hind limb 
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weakness sufficient to impair righting; 3 = one limb paralyzed; 4 = two limbs paralyzed; 5 = 3 or 
more limbs paralyzed or the animal is moribund (mice were euthanized if they reach grade 5).     
3.2.2 Visual acuity (VA) 
The VA of mice was measured daily starting before immunization using the Virtual 
Optometry System (Optomotry, Cerebral Mechanics, Inc., Canada). Briefly, the virtual rotating 
columns were projected on the LCD monitors with different spatial frequencies in cycles/degree 
(c/d). The mouse head movement in response to the virtual column rotations was noted. The 
spatial frequency was increased starting from 0.1 c/d with step size of 0.05 c/d until the mouse 
stopped responding. The VA was defined as the highest spatial frequency of the virtual rotating 
columns to which the mouse was able to respond. We have previously reported that VA of 
normal C57BL/6 mice to be 0.38 ± 0.03 c/d (mean ± S.D., n=30) and defined VA ≤ 0.25 c/d as 
the onset of acute ON for EAE mice [34]. MEMRI was performed on the day when mice 
exhibited VA ≤ 0.25 c/d. The mice in sham group did not develop impaired visual function and 
underwent the same MEMRI procedure at the same time period as EAE group.  
3.2.3 Intravitreal MnCl2 injection 
MnCl2 was injected in the eye that had a measured VA ≤ 0.25 c/d.  Mice were 
anesthetized using 1.5-2% isoflurane/oxygen. After the appropriate level of anesthesia was 
achieved, assessed by the lack of response to toe pinch, mice were placed on a custom-made 
head holder. A 34-gauge needle, connected to a micro-injection pump (WPI Instrument, FL, US), 
was inserted into the posterior vitreous at 1-1.3 mm posterior to limbus. A dose of 50 nmol 
MnCl2, given as 0.25 µL of 0.2 M solution [27], was delivered at a rate of 3 µL/min. At the 
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conclusion of injection, the needle was left in the place for an extra 1 minute before withdrawal 
and then a drop of antibiotic gel was applied to both injected and un-injected eyes[35].  
3.2.4 Manganese-enhanced MRI (MEMRI) 
MEMRI was performed immediately after MnCl2 administration on a 4.7 T Agilent 
DirectDrive small-animal MRI system (Agilent Technologies, Santa Clara, CA) equipped with 
Magnex/Agilent HD image gradient coil (Magnex, Oxford, UK) with pulse gradient strength up 
to 58 G/cm and a gradient rise time ≤ 295 μs. Mice were anesthetized by 1.5% isoflurane/oxygen. 
During experiments, respiratory rate and body temperature were monitored using a MR 
compatible animal monitoring system (SA Instrument, Inc., Stony Brook, NY, US) and 
maintained at 130 – 150 breaths/min and 37˚C with a regulated circulating warm water pad 
underneath mouse body along with regulated warm air blown into the magnet bore, respectively. 
A pair of 8-cm diameter volume (transmit) and 1.7-cm diameter surface (receive) active-
decoupled coils were used.  
A standard 3D gradient echo sequence was employed for T1-weighted (T1W) image of  
the whole mouse brain with the following parameters: repetition time (TR) = 15 ms, echo time 
(TE) = 2.63 ms, flip angle = 20˚, number of averages = 16, field-of-view (FOV) = 15 × 15 × 22 
mm
3
, matrix size = 128 × 128 × 64 (zero-filled to 256 × 256 × 128), acquisition time = 32.8 
minutes. Ten successive sets of 3D-T1W image were captured approximately from 0.55 – 5.5 
hours post-injection.  
3.2.5 B1-inhomogeneity correction 
A 3D-T1W image of a phantom (uniform 13 × 9 × 25 mm
3
 of 2% agar gel placed 
underneath the active-decoupled surface coil with the distance between gel and coil similar to the 
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in vivo study) was acquired using the same MEMRI parameters with 64 averages to obtain the 
profile of surface coil sensitivity (acquisition time was 131.2 minutes). To correct B1 
inhomogeneity, the raw 3D-T1W image of the mouse brain was divided by the 3D-T1W image 
of 2% agar phantom voxel by voxel directly using image calculator in ImageJ [36] and the 
corrected 3D-T1W image data set was generated for analyzing MEMRI data.  
3.2.6 MEMRI data analysis 
Surface-coil sensitivity profile corrected T1W image data set of the final time point was 
displayed using volume viewer plugin version 1.31 in ImageJ 
(http://rsbweb.nih.gov/ij/plugins/volume-viewer.html, NIH, US) with z-aspect factor of 2 
resulting in isotropic 256 × 256 × 256 data matrix. The 3D data matrix was adjusted by rotating 
about x- and z-axis and distance slider to make oblique image plan bisecting both optic nerves. 
The oblique image containing both nerves was saved and converted to 8-bit gray scale. The 
corrected 3D-T1W image data sets of other previous time points were rotated using the same 
rotation parameters. The final result was a stack of oblique corrected T1W images (ten images) 
from each mouse (from 0.55 – 5.5 hours post-injection) for accumulation and transport rate 
calculation.  
To derive the rate of total Mn
2+
 accumulation, ROI of optic nerves were drawn on the 
oblique corrected T1W image at the final time point for each mouse.  The average size of the 
optic nerve ROI was 188 ± 27 voxels (n=160, mean ± S.D.). A 20 × 20-voxel reference area ROI 
was drawn 30 voxels away from optic nerve head. This reference area ROI was pure muscle, not 
affected by Mn
2+
. The ROI information of optic nerves and reference area was saved and then 
applied to oblique corrected T1W images of other previous time points. Finally, the 
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normalization was performed by taking the ratio of signal intensity of optic nerve ROIs and their 
respective reference ROI.   
To calculate Mn
2+
 transport rate, a line ROI was drawn along the signal-enhanced and the 
contralateral optic nerves at the final time point, taking advantage of the increased contrast for 
the ROI definition. The same line ROIs were applied to the corrected T1W images at all time 
points. The average size of Mn
2+
-loaded and reference line ROI was 54 ± 3.3 and 53 ± 3.2 voxels 
(n = 160, mean ± S.D.) respectively. The arrival of Mn
2+
 at the loaded nerve was defined by 
counting voxels with the signal intensity ≥ mean + 2 S.D. of the signal intensity of all voxels in 
the contralateral optic nerve. After determining the number of voxels in the length of Mn
2+
-
enhanced optic nerves was converted to millimeter by combining the known in-plane image 
resolution, the geometric transformation associated with the oblique slice plane and the 
Pythagorean equation [37]. Transport rate was defined as the slope of Mn
2+
-enhanced length 
over time by linear fitting.  
3.2.7 Immunohistochemistry (IHC) of optic nerves 
Following MEMRI experiments, mice underwent intra-cardiac perfusion with 1% 
phosphate buffered saline (PBS) followed by 4% paraformaldehyde in 0.01 M PBS. Brains were 
excised and post-fixed in the same fixative for 24 hours then transferred to 0.01 M PBS for 
storage at 4 ˚C until histological analysis was performed. Mouse optic nerves were dissected 
from each brain and embedded in 2% agar blocks [38]. Then, the agar blocks were embedded in 
paraffin wax and 5-µm thick transverse slices were sectioned for IHC staining. Sectioned slices 
were deparaffinized, and rehydrated to facilitate binding of antibodies and then blocked using 
solution mixed with 1% bovine serum albumin (BSA, Sigma-Aldrich, MO, USA) and 5% 
79 
 
normal goat-serum solution (Invitrogen, CA, USA) for 20 minutes at room temperature to 
prevent non-specific binding and to increased antibody permeability. Slides were incubated with 
monoclonal anti-phosphorylated neurofilament antibody (SMI-31; 1:1000, Covance, NJ, USA) 
to stain non-injured axons, or with rabbit anti-myelin basic protein antibody (MBP, 1:1000, 
Sigma-Aldrich, MO, USA) to stain myelin sheath [8, 39, 40] at 4˚C overnight. After rinsing, goat 
anti-mouse IgG or goat anti-rabbit IgG conjugated Alexa 488 (1:800, Invitrogen, CA, USA) were 
applied to visualize immunoreactivity of phosphorylated neurofilaments and MBP. Finally, 
slides were covered using Vectashield Mounting Medium with 4’,6-diamidino-2-phenylindole 
(DAPI) (Vector Laboratory, CA, USA) to stain nuclei [40, 41]. Histological slides were 
examined with Nikon Eclipse 80i fluorescence microscope equipped with a 60× water objective, 
and images were captured with a black-and-white CCD camera using MetaMorph software 
(Universal Imaging Corporation, Sunnyvale, CA, USA) at the center of optic nerve. 
3.2.8 Histological data analysis 
The whole field of SMI-31, MBP, and DAPI staining images at 60× magnification were 
captured with the same fluorescence light intensity and exposure time. All captured images were 
converted to 8- bit gray scale and analyzed using threshold, analyze particles and gray level 
watershed segmentation functions in ImageJ (http://bigwww.epfl.ch/sage/soft/watershed/). 
3.2.9 Statistical analysis 
Linear repeated measures models were used to test normalized Mn
2+
-enhancement signal 
intensities at each time point (from 0.55 – 5.5 hours post-injection with 0.55-hour step size) for 
pairwise comparison among shame and EAE mice with moderate and severe ON: sham vs. 
moderate, sham vs. severe, and moderate vs. severe groups. 
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Multiple comparisons for accumulation rate, transport rate, SMI-31, MBP, and DAPI by 
each study group (sham/moderate/severe) were performed using a linear regression model of 
each outcome. P-values for the three pairwise tests (sham vs. moderate, sham vs. severe, and 
moderate vs. severe) were adjusted using Tukey’s HSD (honest significant difference). VA, 
SMI-31, MBP and DAPI were measured once per mouse and their association with the rate of 
change in accumulation or transport was analyzed using Spearman rank correlation coefficients. 
 
3.3 Results 
3.3.1 Visual acuity  
After immunization, daily visual acuity (VA) of sham and EAE mice was measured. 
When mice exhibited VA ≤ 0.25 c/d [34], MEMRI was performed (12 ± 2.1 days post-
immunization, mean ± S.D., n=10). In this study, CS appeared at the same day as the first sign of 
impaired VA. VA at ON onset was different among mice examined and was used to separate 
mice into three groups: sham (VA = 0.35 or 0.4 c/d; CS = 0), moderate ON (VA = 0.2, CS = 1 
for one mouse; VA = 0.25 c/d, CS = 0 for the other four mice), and severe ON (VA = 0 c/d, CS 
=0 for two mice and CS = 2.5 for the other three mice in this group; Fig. 1 A).  
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Figure 3 – 1 Group averaged visual acuity (VA) of sham (n=6) and EAE (n=10) eyes before 
MEMRI experiments. EAE mice were separated based on VA to moderate (VA = 0.25/0.20 c/d) 
and severe (VA = 0 c/d) ON groups (A). A serial time-lapse oblique corrected T1W images from 
representative mice are presented to demonstrate the different degree of Mn
2+
-enhancement of 
optic nerves from sham and EAE mice from 1.1 – 5.5 hours post-injection (B). Mn2+-
enhancement of optic nerves clearly increases with time. At the end time point, mice with the 
lower VA exhibited less Mn
2+
-enhancement reflecting slower axonal transport.  
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3.3.2 The optic nerve Mn
2+
 accumulation rate 
Since the image intensity was used to detect Mn
2+
 arrival, the B1-inhomogeneity 
correction of the surface coil was performed (Lin et al., 2003, Hou, 2006) using the 3D T1W 
image of 2% agar gel. After correction, the averaged intensity of randomly selected line profiles 
on the corrected T1W images was comparable in both vertical and horizontal directions 
suggesting a reasonable B1-field inhomogeneity correction (data not shown).  
A series of time-lapse representative B1-profile corrected oblique T1W images of sham, 
moderate and severe ON mice exhibited different degrees of Mn
2+
-enhancement suggesting 
different axonal transport rates in optic nerves. The hyper-intensity of optic nerve resulting from 
axonal transport of Mn
2+
 was readily visible (Fig. 1 B). The optic-nerve and reference ROI were 
defined (Fig. 2 A). The time course of group averaged signal intensity ratios of optic-nerve to 
reference ROI exhibited different rate of signal enhancement among the sham and EAE mice 
with moderate and severe ON (Fig. 2 B). The accumulation rate of Mn
2+
 in the optic nerve was 
defined as the slope of the linear fit of the data over time.  The group averaged optic nerve Mn
2+
 
accumulation rate (the slopes) of sham, moderate ON, and severe ON mice was 0.16, 0.13, and 
0.10 a.u./hour, respectively (Table 1; Fig. 2C). The accumulation rate in EAE mice was 
significantly slower than that of the sham by 19% (moderate ON, p < 0.005), and 38% (severe 
ON, p < 0.005). The accumulation rate was 23% (p < 0.05) slower in the EAE mice with severe 
ON than that with the moderate ON. The accumulation rate correlated with VA (r = 0.87, p < 
0.0001).  
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Figure 3 – 2 The ROI of optic nerve and reference area of muscle, where Mn2+ does not reach, 
were defined on the corrected T1W oblique image at each time point (A). The group average of 
the normalized optic nerve signal intensity from sham, moderate ON and severe ON mice was 
obtained for each time point from 0.55 – 5.5 hours after injection at a 0.55 hours resolution. The 
higher rate of Mn
2+
 accumulation over time was associated with the better VA (B). The group 
averaged slope of the normalized signal intensity over time was defined as the optic nerve 
accumulation rate of total Mn
2+
. The box plots reveal that Mn
2+
accumulation rate of severe ON 
optic nerves was slower than that of the moderate ON nerves, which was slower than that of the 
same nerves (B and C). 
* indicates p < 0.05 
** indicates p < 0.005  
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3.3.3 Transport rate of Mn
2+
 
The Mn
2+
-loaded and contralateral optic nerve reference line ROIs were defined (Fig. 3 
A). The enhanced T1W intensity of the optic nerve after Mn
2+
 loading was readily discernible 
after the subtraction of mean line ROI intensity of the reference optic nerve (Fig. 3 B – D).  
Representative difference images of sham and EAE mice with moderate ON exhibited different 
length of the Mn
2+
-enhanced optic nerve. The entire optic nerve was enhanced at 3.3 and 5.5 
hours post-injection for sham (Fig. 3 B) and EAE mice with moderate ON (Fig. 3 C), 
respectively. In EAE mice with severe ON, only partially enhanced optic nerve was seen (Fig. 3 
D). The time course suggested that the group-averaged time to enhance the entire optic nerve 
took 3.3 and 4.95 hours for sham and EAE mice with moderate ON, respectively (Fig. 3 E). The 
slope of each group represents the transport rate (% of optic nerve/hour). The group averaged 
Mn
2+
 transport rate of sham, moderate ON, and severe ON mice was 26, 14, and 8 % of optic 
nerve/hour (Fig. 3 E). The Mn
2+
 transport rate converted to mm/hour was: 0.92, 0.52, and 0.32 
mm/hour for the sham, moderate ON, and severe ON mice, respectively (Table 1). The transport 
rate of EAE mice was decreased compared with sham mice by 43% (p < 0.05) and 65% (p < 
0.005) respectively for moderate and severe ON groups. EAE mice with moderate ON exhibited 
a non-significant trend of faster transport rate than severe ON mice (p = 0.15). The transport rate 
correlated well with the VA (r = 0.85, p <0.0001).    
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Figure 3 – 3  To estimate Mn2+ transport rate in mm/hour, line-ROIs were defined to match the 
optic nerve length (A). The arrival of Mn
2+
 in optic nerves was defined by the T1W enhancement 
of the optic nerves referencing to the line-ROI of the non-loaded eye. To visualize the extent of 
Mn
2+
-enhancement, representative oblique-corrected T1W images from each group were 
displayed after subtracting the mean intensity of the reference line-ROI (B, C, and D). Three 
representative subtracted images of sham, moderate ON and severe ON mice (VA = 0.4, 0.25, 
and 0, respectively) show different degree of Mn
2+
 transport at 1.1, 3.3, and 5.5 hours post-
injection (B, C, and D). For quantification of the transport rate, the arrival of Mn
2+
 was 
determined using non-subtracted images at each time point by identifying line-ROI voxels of the 
loaded eye with intensity higher than two standard deviation of the mean from the reference line-
ROI of the non-loaded eye. The group averaged displacements, normalized to the total number of 
voxels of each nerve (red line, panel E), of Mn
2+
 over time revealed different rate of Mn
2+
 
transport among the three groups of mice examined (E). Box plot shows transport rate 
distribution of each group in mm/hour by converting normalized voxel displacement to mm (F). 
The results demonstrated that Mn
2+
 transport rate of sham optic nerves were significantly faster 
than moderated ON (p < 0.005) and severe ON (p < 0.005) suggesting the presence of axonal 
transport impairment at the onset of ON in EAE mice.   
* indicates p < 0.05 
** indicates p < 0.005  
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Table 3 – 1  
Group averaged accumulation and transport rates of sham (n=6), moderate ON (n=5) 
and severe ON (n=5)  
Sham 
(n=6) 
0.16 ± 0.01 
Moderate ON 
(n=5) 
0.92 ± 0.14 0.52 ± 0.17 
0.13 ± 0.01 0.10 ± 0.02 
0.32 ± 0.21 
Moderate ON 
(n=5) 
Accumulation Rate (a.u./hour): mean ± S.D. 
Transport Rate (mm/hour): mean ± S.D. 
Accumulation Rate 
Transport Rate 
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3.3.4 Immunohistochemistry (IHC) of optic nerve  
Post-image SMI-31, MBP, and DAPI staining of optic nerves from  sham and EAE mice 
with moderate and severe ON was used to assess the integrity of axons and myelin sheaths, and 
the extent of cellularity (Fig. 4A). Diminished SMI-31 positive axon density suggested axonal 
injury in EAE mice with moderate and severe ON. Myelin damage of EAE optic nerves was also 
evident by the decreased density of MBP positive axons. Increased number of DAPI positive 
nuclei in EAE optic nerves was observed, consistent with cellular inflammation (Fig. 4 A). The 
SMI-31 positive axon counting showed a significantly diminished intact axon density in optic 
nerves from EAE mice with moderate (5.6 ± 0.5 × 10
5
, p < 0.005, Fig. 4 B) and severe (4.5 ± 0.9 
× 10
5
, p < 0.005, Fig. 4 B) ON. The significant loss of MBP positive axons expressed as area 
fraction in optic nerves with moderate (41.6 ± 2.0 %, p < 0.05, Fig. 4 B) and severe (34.0 ± 3.4 
%, p < 0.005, Fig. 4 B) ON was also observed compared with the sham group (48.3 ± 3.9 %). 
DAPI positive cell nuclear staining was significantly increased in optic nerves from mice with 
severe ON (9.1 ± 3.3 × 10
3
) when compared with the sham (3.9 ± 0.6 × 10
3
, p < 0.005, Fig. 4B) 
and moderate ON (5.4 ± 1.0 × 10
3
, p < 0.05, Fig. 4B) mice. However, the difference between 
sham (3.9 ± 0.6 × 10
3
) and mice with moderate ON (5.4 ± 1.0 × 10
3
, p = 0.1, B) was not 
significant. Visual function (measured by VA) highly correlated with SMI-31 (r = 0.84, p < 
0.0001), MBP (r = 0.88, p < 0.0001), and DAPI (r = -0.81, p = 0.0002). The Mn
2+
 accumulation 
and transport rate correlated well with the extent of axonal injury (r = 0.85 and r = 0.86, 
respectively, p < 0.0001) assessed by the density of SMI-31 positive axons, myelin injury (r = 
0.91 and r = 0.82, respectively, p < 0.0001) assessed by the MBP positive axons, and 
inflammation (r = -0.83 and r = -0.84, respectively) assessed by the density of DAPI-positive 
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nuclear staining (Fig. 5A – F). Moreover, total amount of Mn2+ accumulation rate correlated well 
with Mn
2+
 transport rate (r = 0.78, p = 0.0003, Fig. 5G).   
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Figure 3 – 4 Representative immunohistochemical staining of optic nerves from sham, moderate 
ON and severe ON mice (A). Images displayed are 56% field-of-view from the 60× 
magnification of phosphorylated neurofilament (SMI-31, green), myelin basic protein (MBP, 
red), and 4’, 6-dianidino-2-phenylindole (DAPI, blue). Reduced density of SMI-31 positive 
axons was seen in optic nerve from moderate and severe ON mice. Increased number of SMI-31 
positive areas, may reflect axonal beading or debris (A, yellow arrows), were observed with 
increased severity of VA. Decreased density of MBP positive axons was also seen with increased 
VA impairment. The increased DAPI positive nuclear staining was seen with increased VA 
impairment. Box plots demonstrate the difference in axonal pathologies among the three groups 
examined (B). 
 
Scale Bar: 25 μm 
*p < 0.05 
**p < 0.005 
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Table 3 – 2  
Quantitative immunohistochemistry results of sham (n=6), moderate ON (n=5) and 
severe ON (n=5) 
SMI-31 
(#/mm2) 
7.2 (± 0.5) × 105 
DAPI 
(#/mm2) 
 
5.6 (± 0.5) × 105 41.7 ± 2.0 
48.3 ± 3.7 3.9 (± 0.6) × 10
3
 
5.4 (± 1.0) × 103 
MBP 
(Area %) 
Area % of MBP: comparing to entire 60× image (0.017 mm2)  
Counts: mean ± S.D.  
Sham (n=6) 
Moderate ON (n=5) 
4.5 (± 0.9) × 105 34.0 ± 3.4 9.1 (± 0.3) × 10
3
 Severe ON (n=5) 
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Figure 3 – 5 The scatter plots of axonal transport, assessed in accumulation rate (A – C) or 
transport rate (D – F). Results suggested that impaired axonal transport correlated with the 
severity of axonal injury, demyelination, and inflammation respectively. Accumulation rate 
correlated with transport rate suggesting both reflecting axonal transport in optic nerve of EAE 
(G). 
 
  
93 
 
3.4 Discussion 
In this study, we measured the visual function by optokinetic response (to reflect VA; Fig. 
1A) and correlated it with axonal transport of optic nerves quantitated using MEMRI at optic 
neuritis onset during mouse EAE (Fig. 1B). The rate of Mn
2+ 
transport in EAE-affected optic 
nerves was significantly impaired (Fig. 1 – 3) indicating defective fast axonal transport at the 
onset of ON [42]. Immunohistochemistry of these tissues also indicated the presence of 
demyelination, inflammation, and axonal injury in optic nerves with ON (Fig. 4B). Each of these 
axonal pathologies correlated well with decreased axonal transport rate. 
The rate of axonal Mn
2+
 accumulation has been reported to reflect axonal transport in 
mice [43-46]. In the literature, a linear fit of the MEMRI data over a short time course (< 1 hour) 
was commonly employed. In this study, a 5.5-hour time course was pursued. A linear repeated 
measures model accounting for the correlation between observations over time applied to the 
serial 10 measurements suggested that a linear fit was reasonable (data not shown). Thus, a more 
complex modeling [26, 47] was not pursued in this study to analyze the MEMRI time course 
data. In addition to this widely employed Mn
2+
 accumulation rate, the current study also assessed 
axonal transport rate in optic nerves at the onset of ON caused by EAE. The reported fast axonal 
transport rate ranges between 3 – 16 mm/hour [42, 48]. The Mn2+ transport rate by MEMRI has 
been reported ranging between 0.64 – 5 mm/hour, estimated by a two-point time-lapse 
measurement [27, 28, 49-53]. In the present study, the Mn
2+
 transport rate in sham optic nerves 
was 0.92 ± 0.14 mm/hour, at the lower end of published values. Animals in the current study 
were under isoflurane anesthesia throughout the course of the measurements. The lower axonal 
transport rate estimated herein may result from the long period of anesthesia [54, 55]. The 
transport rate estimated using data from the initial 0.55 hours was 1.33, 1.49, and 1.31 mm/hour 
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in sham, moderate and severe ON groups, respectively. The higher initial rate supported the 
possible effect of prolonged anesthesia on the measured transport rate. The varied rate of 
transport using the initial time-lapse data immediately after injection may reflect the variable 
severity of ON among mice, or the variable response of individual mice to the induction of 
anesthesia, masking the transport rate difference among groups. The linear increase over time of 
MEMRI length of the optic nerve between 0.55 – 5.5 hours from all groups suggested that a 
steady-state of anesthesia was reached 0.55 hours after the injection of Mn
2+
.  
The axonal Mn
2+
 transport rate between moderate and severe ON groups was not 
statistically different (Fig. 3F). This may be due to the variation in axonal pathologies of the 
severe ON group, leading to a high standard deviation in that group. It may also be due to 
imprecision of the method of VA measurement [56]. Optic nerves from three EAE mice with 
severe ON were not fully enhanced at the end of 5.5 hours post-injection (Fig. 3 E) while the 
remaining two exhibited whole optic nerve enhancement at 4.4 and 4.95 hours. These two mice 
also exhibited axonal injury (25% decrease in SMI-31 staining compared with the control) 
comparable to that in the moderate ON mice (22 ± 7%). IHC results indicated that the mice with 
higher transport rates suffered less axon and myelin damage than those with slower transport 
rates. It is possible that acute vasogenic edema at the ON onset impeded action potential 
propagation and thus reduced VA without significant axonal pathologies [18, 57].  
Why might axonal transport be affected in early inflammatory demyelination? Axonal 
transport depends on energy supplied by mitochondria [58]. In MS and its animal model EAE, 
several pathologies conspire to reduce energy supply. Nitric oxide and the free radical/reactive 
oxygen species are increased, including within axons, and inhibit mitochondrial function [59] 
reducing energy production. Sodium channel redistribution in demyelinated axons reduces 
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internode length, thereby increasing the energy consumption needed for signal propagation [33, 
60, 61].  The potential energy deficit would eventually lead to failure of the Na
+
/K
+
-ATPase 
pump (which requires energy for maintenance) and increased intracellular Na
+
, thus triggering 
the reversal of Na
+
/Ca
2+
 exchanger. The resultant influx and accumulation of intracellular Ca
2+
 
may then lead to further mitochondrial dysfunction and axonal damage [62-66]. Excessive 
glutamate production by inflammatory cells, coupled with reduced buffering capacity of glial 
cells leads to glutamate-induced excitotoxicity of axons (which express glutamate receptors) in 
EAE [63, 66-69], and results in inhibition of mitochondrial mobility and function [70, 71]. 
Therefore, a vicious cycle of disruption of ion homeostasis, energy deficits, and axonal transport 
deficits could play a crucial role in axonal degeneration [42, 48, 64, 72].  
Since APP is a post-mortem biomarker as early axonal transport disruption and indicates 
axonal injury, we speculate axonal transport disruption is an early event of axonal pathologies. 
Although the current data are not sufficient to determine whether the impaired axonal transport is 
the result or the cause of axonal injury at the onset of ON, its association with various axonal 
pathologies has been reported.  Excess nitric oxide and reactive oxygen species are produced 
during neuroinflammation. These species have been shown to decrease axonal transport in vitro 
[73, 74]. In other studies, excessive nitric oxide was shown to reversibly block impulse 
conduction in demyelinated CNS axons of rodents [75] while reduction in nitric oxide at the 
inflammation site prevented further axonal degeneration [76]. Demyelination was also reported 
to result in axonal transport disruption in EAE mice [77, 78]. Phosphorylated neurofilaments 
play a role in regulating axonal transport [79, 80]. Our current findings that decreased axonal 
transport correlated with reduced SMI-31 (marker of phosphorylated neurofilaments) and MBP 
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(marker of myelination), and increased DAPI staining (marker of cell nuclei that is increased 
during inflammation) are consistent with these literature reports.  
In summary, this study revealed the presence of impaired optic nerve in vivo axonal 
transport in the early stages of ON in EAE mice. The degree of decrease of the axonal transport 
rate correlated with severity of impaired visual function, and axonal pathologies including axonal 
injury, demyelination, and inflammation. Preventing and improving the early axonal transport 
deficit may be a potential treatment target to halt the degeneration of axons in MS. We have 
demonstrated the feasibility of quantitatively assessing axonal transport in EAE mice, suitable 
for a future pre-clinical drug development targeting axonal transport. Measuring axonal transport 
using MEMRI would not be a viable option in humans due to the potential toxicity of Mn
2+
. 
However, preventing axonal degeneration by targeting axonal transport may be assessed by 
using axonal integrity as the outcome measure monitored using techniques such as diffusion 
MRI.  
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Chapter 4  
White-Matter Diffusion fMRI of Mouse Optic Nerve  
This chapter represents a modified version of a manuscript initially published in NeuroImage. 
(William M. Spees, Tsen-Hsuan Lin, Sheng-Kwei Song White-Matter Diffusion fMRI of Mouse 
Optic Nerve. NeuroImage, 2013, 65: 209-215)  
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Abstract 
Non-invasive assessment of white-matter functionality in the nervous system would be a 
valuable basic neuroscience and clinical diagnostic tool.  Using standard MRI techniques, a 
visual-stimulus-induced 22% decrease in the apparent diffusion coefficient of water 
perpendicular to the axonal fibers (ADC) is demonstrated for C57BL/6 mouse optic nerve in 
vivo.  A slight increase in ADC|| (diffusion parallel to the optic nerve fibers) was observed during 
visual stimulation.  The stimulus-induced changes are completely reversible.  A possible vascular 
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contribution was sought by carrying out the ADC measurements in hypercapnic mice with and 
without visual stimulus.  No differences were seen between room-air-breathing and hypercapnic 
animals.  The in vivo stimulus-induced ADC decreases are roughly similar to literature reports 
for ex vivo rat optic nerve preparations under conditions of osmotic swelling.  The experimental 
results strongly suggest that osmotic after-effects of nerve impulses through the axonal fibers are 
responsible for the observed ADC decrease.  
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4.1 Introduction 
 Currently functional MRI (fMRI) studies are limited almost exclusively to gray matter, 
and rely upon coupling of hemodynamic response to functional activation [1].  Signal 
modulations on the order of 1 – 5% are typical.  The limited capacity for physiologic modulation 
of blood flow and the inherently lower fractional blood volume probably account for the 
difficulty in monitoring white-matter functional activation with standard BOLD (Blood Oxygen 
Level Dependent) fMRI techniques [2, 3].  Thus, at present, white-matter MRI is largely 
restricted to probing the structural integrity of fiber tracts using diffusion tensor imaging or 
variants thereof [4]. 
 Diffusion weighting has been investigated as a potential alternative to BOLD for 
monitoring neuronal activity in gray matter of the human visual cortex [5].  An ~1 - 2% increase 
in diffusion weighted MRI signal intensity was reported (b = 1.8 ms/m2), suggested to arise 
from activity-dependent cell swelling.  In a subsequent report, a similar diffusion-weighted MRI 
signal intensity increase was elicited via hypercapnia-induced brain blood flow enhancement 
without neuronal activation [6].  Thus, the specificity of diffusion fMRI signal change to 
neuronal activity may be confounded by a sizeable vascular contribution. 
 In ex vivo rat optic nerve preparations, repeated electrical stimulation produces 
frequency- and duration-dependent shrinkage of the extracellular space (ECS), with higher 
frequencies and longer stimulus trains resulting in a more pronounced ECS reduction [7].  A 
consensus has emerged that the observed ECS shrinkage results from an osmotic shift of water 
into glial cells as part of a mechanism for maintaining extracellular ionic balance and neuronal 
electrophysiologic competence [8-11].     
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 To determine the feasibility of detecting diffusion weighted MRI signal changes in white 
matter responding to functional stimulation, as well as the specificity of this signal change to 
axonal activation, optic nerves from room-air-breathing and hypercapnic mice were examined 
with and without the application of visual stimulus.  
 
4.2 Materials and Methods 
4.2.1 Animal 
All experimental procedures were in compliance with the protocol approved by the 
Washington University Animal Studies Committee.  Female C57BL/6 mice, aged 10 – 12 weeks, 
obtained from Jackson Laboratory (Bar Harbor, ME) were used in the experiments. 
4.2.2 Visual Acuity  
  Prior to MRI experiments, visual acuity of each mouse was measured with a Virtual 
Optokinetic System (CerebralMechanics, Inc.) as previously reported [12], to ensure normal 
vision. 
4.2.3 Animal Monitoring  
Respiratory rate and rectal temperature of anesthetized mice were monitored during 
experiments using an MR-compatible animal monitoring system (Small Animal Instruments, Inc., 
Stony Brook, NY) to ensure physiologic stability.  A body-core temperature of 37ºC was 
maintained via a circulating warm water pad placed underneath the animal and thermostated 
warm air blown into the magnet bore. 
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4.2.4 Anesthesia 
 The anesthesia regimen employed has been shown to maintain fMRI-observable 
neuronal response in mice [13].  Anesthesia was induced with 2.5% isofluorane in O2, and 
reduced to 1.5% for placement of the animal in the imaging cradle.  After positioning of the 
animal in a head holder and achieving a stable respiratory rate, a subcutaneous 0.3 mg/kg bolus 
of medetomidine was administered.  Beginning three minutes after the bolus injection, 
isofluorane levels were reduced by ~ 0.2% per minute until the inhaled gas consisted of 100% O2.  
At 10 minutes after the bolus injection, continuous subcutaneous infusion of medetomidine was 
initiated at a rate of 0.6 mg/kg/hr, and the nose cone for inhalant anesthetics was removed, 
leaving the animal breathing room air for the duration of the MR experiment.  In experiments 
investigating the effect of hypercapnia (air vs. 5% CO2/95% O2), the animal, head holder, and 
other equipment was placed in a closed plastic tube that allowed control of breathing gas 
composition.    
4.2.5 Magnetic Resonance Imaging 
MRI experiments were performed on a 4.7-T Agilent DirectDrive
TM
 Small-Animal MRI 
system (Agilent Technologies, Santa Clara, CA), equipped with Magnex/Agilent HD imaging 
gradients (Magnex/Agilent, Oxford, UK).  The gradient hardware, interfaced with a set of IEC 
300 A gradient power amplifiers (International Electric Company, Helsinki, Finland), is capable 
of pulsed gradient strengths up to 58 G/cm with a gradient rise time ≤ 295 s.   An actively-
decoupled volume (transmit)/surface (receive) coil pair was used for MR excitation and signal 
reception [14].  A diffusion-weighted, multi-echo spin-echo imaging sequence [15] was 
employed for scout images and also for the final targeted diffusion-weighted images (Fig. 4 – 1).  
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To minimize partial volume effects in optic nerve diffusion measurements, the image plan was 
adjusted to ensure that, as nearly as possible, the optic nerve fibers were orthogonal to the image 
slice plane (Figs. 4 – 2b and 4 – 2c).  Image acquisition parameters included a slice thickness of 
1.3 mm and a 20  20 mm2 (256  256) field-of-view.  A sequence repetition time of 1.5 s was 
employed, thus the total acquisition time for a pair of diffusion-weighted images probing a single 
diffusion direction was 12.8 minutes.  To increase accumulated signal-to-noise ratio for each 
phase-encoding step, a train of three echoes were co-added to form the final MR images.  The 
first echo time (which included a pair of diffusion-weighting gradient lobes centered about the 
180 refocusing pulse) was 37.1 ms, with a spacing of 23.6 ms between the first and all 
subsequent echoes without diffusion gradients. 
Some evidence for attenuated changes in ADC with repeated applications of visual 
stimulus after the initial “on” block was seen (data not shown).  This could possibly result from 
accumulation of inactive forms of retinal rhodopsin during the rather lengthy 12.8-minute 
stimulus block [16].  To avoid potentially confounding results, ADC and ADCǁ were measured 
in separate cohorts of animals.       
For each experimental condition (e.g., baseline, visual “stimulus on”, post- “stimulus off”, 
etc.) a pair of diffusion-weighted images with different diffusion weightings was acquired (Fig. 4 
– 2c).  For the cohort in which ADC was evaluated, b values of 0.10 ms/m
2
 and 1.40 ms/m2 
were used ( = 5 ms,  = 18 ms, Gdiff = 6 G/cm or 22.6 G/cm for a pair of trapezoidal diffusion-
weighting gradients).  Because of the much less restricted diffusion along the axis of the optic 
nerve (Fig. 4 – 3), measurements in the ADC|| cohort were made based on a pair of diffusion-
weighted images having b values of 0.10 ms/m2 and 0.70 ms/m2 ( and  were the same as for 
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ADC measurements, but Gdiff = 6 G/cm or 15.5 G/cm).  It is worth pointing out that, in the 
diffusion MR literature, b values reported in units of s/mm
2
 are not uncommon, with ADC being 
reported in mm
2
/s units in that case.  To convert to those units, our numerical values for b should 
be multiplied by 1,000 and our ADC numbers divided by 1,000. 
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Figure 4 – 1 Pulse sequence diagram for the diffusion-weighted multi-spin-echo sequence.  
Timing parameters include:  = 5 ms,  = 18 ms, TE = 37.1 ms TE2 = 23.6 ms.  
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Figure 4 – 2 Typical scout planning images (a,b), final targeted images for diffusion 
measurements (c,d), and ADC maps of an optic nerve without (e) and with visual stimulation 
(f).  (a) A multi-slice set of axial images of the mouse brain is acquired with a non-diffusion-
weighted multi-echo spin-echo image (only a single slice is shown here) are used to plan sagittal 
slices, indicated by the white lines.  (b) The center sagittal slice, acquired with diffusion-
weighting gradients applied in the slice-select direction, captures both optic nerves (arrow) and is 
used to target the slice for measurements of ADC and ADCǁ.  (c)  A pair of diffusion-weighted 
images with diffusion-sensitizing gradients applied in the phase-encode direction (left-to-right in 
the images).  The optic nerve fibers are perpendicular to the slice plane in this final targeted slice.  
(d)  Magnified view of the area within the red box of panel c.  Both optic nerves are visible with 
the stimulated optic nerve indicated by the red arrow.  Color maps of ADC in an experimental 
optic nerve without (e) or with (f) visual stimulation.  
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Figure 4 – 3 Diffusion attenuation curves for mouse optic nerve with diffusion weighting 
perpendicular and parallel to the nerve fibers (without visual stimulation), acquired with ( = 5 
ms,  = 18 ms).  Parallel diffusivity is essentially mono-exponential.  It is readily apparent that 
diffusion perpendicular to the fibers is highly restricted and non-monoexponential.  The blue and 
red curves are constructed with ADC = 0.11 m
2
/ms (blue curve, representative of activated 
optic nerve) and ADC = 0.16 m
2
/ms (red curve, representative of unstimulated optic nerve).  
The estimated changes in ADC from the mono-exponential data modeling indicate an 
approximately 5.7% signal increase at b = 1.4 ms/m2 with visual stimulation.    
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4.2.6 Visual Stimulation 
Visual stimulation was achieved by repetitive flashing of a high-intensity, white LED 
(Cree, Model C503C-WAS) fixed at a position 5 cm in front of the animal’s nose and aimed at 
one of the animal’s eyes.  Light was blocked out of the contralateral eye with two layers of black 
electrical tape.  A step-function signal of 1.4 Hz frequency [17], 200 ms on/514 ms off, with 
amplitude of 4 V/0 V (on/off) was provided by a Grass Instruments S9 stimulator (Grass 
Technologies, West Warwick, RI).  With a 100  series current-limiting resistor, the forward 
voltage across the LED is 3.2V.  The circuit draws 8 mA of DC current in the “on” state, 
corresponding to a luminous intensity of ~ 14 candela.  DC current was carried from the 
stimulator (outside the magnet) through the LED (inside the RF-shielded bore of the magnet) by 
a pair of coaxial BNC cables.  Additionally, a pair of 3-segment LC filters was placed on each 
BNC line where it fed into the magnet bore to eliminate delivery of unwanted RF interference 
into the magnet.  The outer conductor of each BNC line was grounded to the magnet’s RF shield 
at the feedthrough into the magnet.  In MRI measurements with “stimulus on”, the flashing light 
stimulus was applied for the entire 12.8-minute duration of the imaging acquisition. 
   While white matter tends to be less well-vascularized than gray matter structures, the 
vascularization of the mouse optic nerve is not negligible, with retinal venous drainage routed 
within close proximity to the ROI investigated [18].  In order to determine the effect of possible 
dilation of optic nerve vasculature and associated changes in blood oxygenation level on the 
observed ADC decrease, “baseline” and “stimulus on” measurements were also made in 
anesthetized mice breathing a mixture of 5% CO2/95% O2 (n = 5).  In cases where the breathing-
gas composition was changed, a period of 5 minutes was allowed prior to the commencement of 
MR measurements.    
114 
 
4.2.7 Data Processing and Image Segmentation 
All MR images were zero-filled to 512  512 data matrices.  To ensure the absence of 
any possible hardware-related systematic variation in image signal, the ADC was determined in a 
20  20 region-of-interest drawn within the basal forebrain (a brain region not expected to be 
activated with visual stimulation, but located within a reasonable proximity to the optic nerves) 
and the contralateral/control non-stimulated optic nerve from each pair of diffusion-weighted 
images.  The regions of interest (the optic nerves) were manually outlined on an image with b = 
1.40 ms/m2 diffusion-weighting perpendicular to the optic nerve fiber direction, which provides 
fairly clear definition of the optic nerves (Figs. 4 – 2c and 4 – 2d).  Voxels on the outer periphery 
of the optic nerve were excluded from the ROI.  Optic nerve ROIs consisted of ~ 20 voxels or ~ 
30,000 m2 [range: 16 – 26 after zero-filling (24,000 – 40,000 m2), corresponding to 4 – 6 
voxels before zero-filling), for which individual apparent diffusion coefficients were calculated.  
These individual voxelwise values were pooled together for subsequent statistical analyses.   
The signal intensity, S(b), in the range of b values employed for ADC|| and ADC 
estimation is essentially a monoexponential decay, although the signal-decay behavior, it should 
be noted, is more complex than this over a wider range of b values (Fig. 4 – 3).  As is commonly 
done in measurements at only two b values, the following equation (Eq. (4.1)) was employed to 
estimate both ADC|| and ADC:    
 
 
 
 
  ADCbb
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
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
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.        (4.1) 
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The contrast in parallel-diffusion-weighted images does not readily reveal the definition of the 
optic nerve.  For measurements of ADC||, each pair of diffusion-weighted images was preceded 
and followed by a single diffusion-weighted image with diffusion gradients applied 
perpendicular to the nerve fibers and b = 1.40 ms/m2.  The definition of the ROI was then 
prescribed referencing the images acquired with perpendicular diffusion weighting. 
4.2.8 Statistical Tests 
One-way ANOVA with Tukey test post-hoc means comparison was performed to assess 
differences between group data (e.g., ipsilateral optic nerve: “baseline” vs. “stimulus on” vs. 
“stimulus off”, contralateral optic nerve: “baseline” vs. “stimulus on”, etc.).   
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4.3 Results 
The imaging protocol employed provides good quality images of the mouse optic nerve.  
Signal-to-noise ratio varied across the study animals in the range from 22.3 to 30.3 with low 
diffusion weighting (b = 0.1 ms/m2) and 17.2 to 25.1 for higher diffusion weightings (b = 1.4 
ms/m2).   
In the cohort of animals for which ADC was measured (n = 5 mice), a sizeable and 
statistically significant 22% decrease (p = 0.0019, Baseline vs. Stimulus On) from 0.172 ± 0.004 
m2/ms to 0.134 ± 0.003 m2/ms (mean ± sem, see Fig. 4 – 4 and Table 4 – 1) was observed.  In 
individual animals, the range of ADC decrease with stimulation was between 10% and 34%.  
The change was completely reversible with cessation of visual stimulation.  In the contralateral 
control optic nerve, no systematic variation in ADC was detectable with application of stimulus 
to the ipsilateral eye (Fig. 4 – 4).  Additionally, the ADC measurements from within the 
reference basal forebrain region were quite stable with variations no more than 3% both intra- 
and inter-subject.  From the inset in Figure 4, it can be appreciated that the inter-subject variation 
in ADC is then largely a result of partial volume effects as the mouse optic nerve is surrounded 
by CSF which, by comparison, has a relatively high diffusivity. 
  A small, but still statistically significant increase (3%) in optic nerve ADC|| (p = 3.0 × 
10
-5
) was observed with visual stimulation (Fig. 4 – 5 and Table 4 – 1, n = 6 mice). Similar to the 
ADC measurements, the reduction in ADC|| in the presence of visual stimulus was reversible 
and no changes were detectable in the contralateral optic nerve with visual stimulation.  A 
decreased ADC|| was observed in all ipsilateral optic nerves with visual stimulation, with the 
percent change varying between 7.3% and 13.6% across the members of this cohort.  Again, 
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ADC in the basal forebrain region was very stable across and within animals studied in this 
group.   
Using the ADCǁ and ADC results in Table 1 and assuming cylindrical geometry, the 
fractional anisotropy for mouse optic nerve can be estimated [19].  For the resting state mouse 
optic nerve FA = 0.90.  With the applied flashing-light stimulus FA increases to 0.93.  Via a 
similar analysis, an orientationally-averaged diffusivity, D, of 0.71 m2/ms is estimated for the 
resting-state optic nerve, which decreases by ~ 14 % to 0.61 m2/ms during the application of 
visual stimulus.   
 Hypercapnia, by itself, produced no measureable changes in the optic nerve ADC (Fig. 4 
– 6 and Table 4 – 2, n = 5 mice). An activation-induced reversible 25% decrease in optic nerve 
ADC (p = 0.024) was observed in hypercapnic mice, essentially the same extent as seen in 
room-air-breathing animals.  This strongly suggests that the observed decrease in optic nerve 
ADC with visual stimulation does not arise from a vascular effect [6] and is produced entirely as 
a result of repeated axonal firing.  The effect of hypercapnia and hypercapnia + stimulation on 
ADCǁ was not investigated. 
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Figure 4 – 4 Application of visual stimulus produces a significant drop in ADC for the optic 
nerve of the stimulated eye [Baseline:  0.153  0.007 m2/ms (mean  sem), Stimulus On: 0.110 
 0.006 m2/ms, ++: p = 0.0019], but no change for the contralateral, unstimulated eye.  ADC 
in the ipsilateral optic nerves returns to baseline values once again with removal of the stimulus.  
Quantities shown are the mean  sem for image voxels within the optic nerve ROI in a group of 
five experimental mice breathing room air.  The insets depicts the measurements for the 
experimental/ipsilateral and control/contralateral optic nerves in individual animals.  
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Figure 4 – 5 Stimulus and ADC|| in optic nerve of mice breathing room air. Quantities plotted 
are (mean ± sem). Stimulation produces no statistically-significant changes in ADC|| 
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Table 4 – 1  
Measured ADC (mean  sem, n = 5) and ADC|| (mean  sem, n = 6) for In Vivo Mouse Optic 
Nerve in Room-Air-Breathing Mice. 
Condition Ipsilateral 
ADC 
(m2/ms) 
Contralateral  
ADC 
(m2/ms) 
Ipsilateral  
ADCǁ 
(m2/ms) 
Contralateral 
ADCǁ 
(m2/ms) 
Baseline 0.176  0.019  0.168  0.018c   1.70  0.02 1.69  0.04  
Stimulus On 0.129  0.013a  0.162  0.021d   1.73  0.03f  1.69  0.05  
Stimulus Off 0.166  0.025b  0.169  0.022e   1.69  0.03g  1.63  0.04  
 
a:  p = 0.0008 vs. Ipsilateral “Baseline” group 
b:  p = 0.005 vs. Ipsilateral “Stimulus On” group 
c:  p = 0.004 vs. Ipsilateral “Stimulus On” group 
d:  p = 0.01 vs. Ipsilateral “Stimulus On” group 
e:  p = 0.003 vs. Ipsilateral “Stimulus On” group 
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Figure 4 – 6 The effects of hypercapnia on measured ADC (mean ± sem) with and without 
stimulation were investigated in a set of mice in order to quantify vascular contributions to the 
observed phenomenon.  The effects of stimulation on ADC (a 19% decrease) were similar to 
changes seen in animals breathing room air.     
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Table 4 – 2 
 Measured ADC (mean  sem) for In Vivo Mouse Optic Nerve in Mice Breathing Air or 5% 
CO2/95% O2 (n = 5). 
Condition Ipsilateral 
ADC 
(m2/ms) 
Contralateral 
ADC 
(m2/ms) 
Air, Baseline  0.184  0.022  0.200  0.016d   
5% CO2, Baseline 0.192  0.020 0.198  0.007
e
   
5% CO2 + Stimulus    0.155  0.017
a,b
  0.192  0.011f   
Air, Stimulus Off  0.183  0.025c  0.202  0.019g 
 
a:  p = 0.03 vs. Ipsilateral “Air, Baseline” group 
b:  p = 0.008 vs. Ipsilateral “5% CO2, Baseline” group 
c:  p = 0.04 vs. Ipsilateral “5% CO2 + Stimulus” group 
d:  p = 0.002 vs. Ipsilateral “5% CO2 + Stimulus” group 
e:  p = 0.002 vs. Ipsilateral “5% CO2 + Stimulus” group 
f:   p = 0.007 vs. Ipsilateral “5% CO2 + Stimulus” group 
g:  p = 0.001 vs. Ipsilateral “5% CO2 + Stimulus” group  
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4.4 Discussion 
 Our results show that in vivo diffusion MRI is capable of detecting the ADC decrease 
(~28%) accompanying mouse optic nerve activation in medetomidine-anesthetized mice. The 
activation-associated ADC decrease is independent of blood flow effects since hypercapnia 
alone does not produce observable changes, and a similar activation-induced decrement in ADC 
was seen in hypercapnic and air-breathing mice.  The extent of in vivo ADC change is 
comparable to that reported (31  8% decrease) for depolarization and osmotic swelling of ex 
vivo rat optic nerve at 21ºC [20] supporting the notion that decreased ECS (Sen and Basser, 2005) 
may be responsible for the detected ADC change. 
 Decreased ADC is a hallmark of repeated, synchronous neuronal discharge in CNS.  For 
example, 11 – 35% decreases in ADC were observed in 10 patients with complex partial status 
epilepticus [21].  Application of trains of electrical shocks, administered via carbon electrodes 
placed on the surface the rat brain, have been shown to result in an 8% decrease in gray-matter 
water ADC [22].  Spreading depression also produces a transient ADC drop [23, 24].  While all 
of these conditions produce membrane depolarization and subsequent cellular swelling [24], it is 
likely the cellular swelling aspect that is directly responsible for the observed changes in tissue 
water diffusion.  For instance, membrane depolarization without cell swelling was not sufficient 
to produce changes in ADC in ex vivo rat optic nerve [20]. 
In the current study, repetitive axonal firing within the optic nerve is expected to result 
from the flashing light stimulus.  The frequency of 1.4 Hz for the repetitive light flashing was 
chosen since it is in the region of maximal response in the electroretinogram and visual evoked 
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potential (voltage amplitude vs. flashing-stimulus frequency), as reported previously for 
measurements in C57BL/6 mice [17].    
 In the visual system, light intensity information is encoded by the excitation frequency of 
retinal ganglion cells [25] with faithful transmission of the photoreceptor action potentials to the 
brain via the optic nerve.  It is likely that during the 200ms-long pulses of bright light (repeated 
at 1.4 Hz temporal frequency), the mouse optic nerves are repetitively transmitting action 
potentials at frequencies of many tens of Hz [26, 27].  Ex vivo rat optic nerves have been shown 
to undergo an ECS shrinkage that is more pronounced at higher rates of repeated electrical 
stimulation [7].  While it was not investigated here, we would expect that the ADC response in 
optic nerve should be graded in proportion to intensity of the applied stimulus.  Earlier attempts 
to measure changes in ADC|| and ADC in electrically-stimulated white matter of the ex vivo frog 
spinal cord were unsuccessful [28], possibly due to the low-frequency (2.7 Hz average) of the 
applied electrical stimulus.  
 Taken together, our results for ADC and ADCǁ predict an enhanced relative anisotropy 
for activated white-matter fibers.  Provided that stimulus paradigms can be devised for activating 
specific white-matter pathways [3], it may be possible to monitor brain white-matter activation.  
A recent report was aimed at detecting white-matter diffusion anisotropy changes in humans 
with visual and tactile stimuli [29]. The conclusion reached in that study was that a large number 
of measurements would be required for reliable detection of diffusion MRI signal changes. This 
lack of sensitivity may reflect more on the need for higher spatial resolution (to avoid partial 
volume effects) than a lack of robust physiological response. 
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 In the current study, we have used two diffusion-weighted measurements to estimate the 
ADC of optic nerve with and without visual stimulation, assuming diffusion-attenuated signal 
decays as a single exponential.  As can readily be seen from Figure 3, this is approximately 
correct over the range of b values employed for estimation of ADC and ADC||.  Measurement 
with diffusion-weighting perpendicular to the optic nerve and b = 1.40 ms/m2 result in a 
relative signal intensity change of ~ 5.7% with vs. without stimulation.  
 Hypercapnia, a potent vasodilator and modulator of CNS blood flow (Rostrup et al., 
2000), by itself did not elicit signal changes in the mouse optic nerve.  A modulation in tissue 
ADC is one conceivable consequence of vasodilation (increased delivery of oxygenated blood) 
with the same level of tissue oxygen consumption.  The vascular network, especially the venous 
network, contains some amount of relatively paramagnetic deoxyhemoglobin.  The confinement 
of this paramagnetic material to the venous network produces unintended tissue-internal 
magnetic field gradients (in addition to the intentionally-applied diffusion-weighting gradients).  
Reducing the tissue-internal field gradients, by reducing vascular deoxyhemoglobin content, can 
produce an increased tissue ADC [30, 31].  No such effects were observable in hypercapnic mice 
and essentially the same relative decrease in ADC was seen with stimulation in hypercapnic and 
room-air-breathing animals.     
 We believe that ECS shrinkage in the optic nerve with visual stimulation is the cause of 
the observed ADC decrease.  Interestingly, for both the rat optic nerve [7] and rat spinal cord 
gray matter [10], the extent of activity-dependent ECS shrinkage (from repeated electrical 
stimulation) is correlated with age of the animal.  Both sets of authors noted that a key 
developmental feature in the maturation of these tissues is gliogenesis. Glial cells are often 
implicated as the dominant contributors to activity-induced ECS shrinkage in neural tissue [32, 9, 
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8].  As recently reviewed by Rash [11] the pan glial syncytium (involving gap-junction-
interconnected astrocytes, epindymocytes and oligodendrocytes--including direct involvement of 
myelin-bounded cytoplasmic spaces), is believed to provide a dynamic mechanism for potassium 
siphoning.  This means of moving K
+
 and osmotically accompanying water away from the 
axonal exterior is believed to allow for re-establishment of axonal membrane polarization 
required for the repeated propagation of action potentials.   
 It should be noted, that in addition to glial swelling, there is evidence for activity-
dependent swelling of neuronal processes.  Long-lasting swelling of dendritic spines has been 
reported following a 30-second period of in vivo electrical stimulation in mouse brain [33].  Also, 
transient axonal swelling, coincident with passage of the compound action potential has been 
observed in the non-myelinated garfish olfactory nerve ex vivo [34].  Thus neuronal cells may 
make some additional contribution to activity-dependent shrinkage of the extracellular space in 
white matter.  Regardless of the precise cellular origins, ECS shrinkage would be expected to 
result in an overall reduction in tissue water diffusivity.  Indeed, in mathematical modeling of 
diffusion in white matter, the extracellular volume fraction is shown to be a dominant factor in 
determining the overall tissue diffusion characteristics [35]. 
 Regardless of any role that myelin itself might play in ECS shrinkage, which we believe 
to be at the root of the stimulus-induced ADC changes in the optic nerve, intact myelin is a 
requirement for normal white-matter functionality [36].  This suggests that functional diffusion 
MRI measurements in white matter tracts could find utility as a specific marker of white-matter 
lesions in demyelinating diseases (e.g., multiple sclerosis) with possible utility in directly 
monitoring disease progression or treatment response.     
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Chapter 5 
Diffusion fMRI detects white-matter dysfunction in mice with acute optic 
neuritis 
This chapter represents the latest version of a manuscript that is targeted for submission to 
NeuroImage. 
(Tsen-Hsuan Lin, William M. Spees, Kathryn Trinkaus, Chia-Wen Chiang,
 
Anne H. Cross, and 
Sheng-Kwei Song)
 
 
Abstract 
Optic neuritis is a frequent first sign of multiple sclerosis (MS). Conventional magnetic 
resonance (MR) techniques provide a means to assess multiple MS-related pathologies, including 
axonal injury, demyelination, and inflammation.  However, a method to directly and non-
invasively probe white-matter function could further elucidate the interplay of pathology and 
dysfunction.  Previously, we demonstrated a significant 27% activation-associated decrease in 
the apparent diffusion coefficient of water perpendicular to the axonal fibers (ADC) in normal 
C57BL/6 mouse optic nerve with visual stimulation using diffusion fMRI.  Here we extend this 
approach to explore the relationship between visual acuity, pathology, and diffusion fMRI in the 
experimental autoimmune encephalomyelitis (EAE) mouse model of optic neuritis. Visual 
stimulation produced a significant 25% decreased in ADC in EAE sham optic nerves, while 
only a 7% ADC decrease was seen in acute-stage EAE mice. The reduced ADC response was 
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consistent with impaired visual function in EAE eyes. Immunohistochemistry (IHC) data 
confirmed pathologies of EAE optic nerves including axonal injury, demyelination, and 
inflammation. These pathologies contributed impaired visual function and presumably produce 
the resulting reduced activation-associated ADC response. Diffusion fMRI holds promise for 
directly gauging in vivo white-matter dysfunction.  
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5.1 INTRODUCTION 
Multiple sclerosis (MS) is an inflammatory and neurodegenerative disease that mainly 
affects the central nerve system (CNS), such as brain, optic nerve, and spinal cord [1-3]. Optic 
neuritis is an inflammatory disorder of optic nerve and a frequent first sign of MS, which 
produces blurred vision and/or pain in the affected eye due to inflammation and demyelination at 
foci within optic nerve. The ten- and fifteen-year risk of developing clinically MS following a 
single episode of optic neuritis was 38% and 50%, respectively [4, 5]. Hence, investigating and 
treatment of optic neuritis might be crucial to reduce later development of MS and long-term 
disability due to the significant relationship between MS and optic neuritis [6]. Therefore, 
investigating functional deficits of optic neuritis may prevent or improve MS. Experimental 
autoimmune encephalomyelitis (EAE), which is induced by inoculation with myelin 
oligodendrocyte glycoprotein (MOG) peptide, is an animal model of human MS.  Many 
pathological features in EAE models parallel those characteristic of MS, including demyelinating 
autoantibody response, axonal injury and loss, infiltration of encephalitogenic T cells and 
macrophages, activation of microglia, microphages and astrocytes [7-10].   
Non-invasive MR measurement has been widely used to investigate or diagnose 
pathologies in EAE animal models and MS patients [11, 10, 12, 13, 2]. For instance, the apparent 
diffusion coefficient (ADC), axial and radial diffusivity, mean diffusivity (MD), and fractional 
anisotropy (FA) derived from diffusion-weighted images (DWI) or diffusion-tensor images (DTI) 
can be used to identify axonal injury, demyelination, inflammation, and axonal loss [14, 7, 15-
17]. T1- and T2- weighted hypointensities result from higher cellularity and T2-weighted 
hyperintensities reflect vasogenic edema, demylination, and axonal loss. Also, T1-weighted 
contrast-enhanced images using Gd-DTPA or Mn
2+
 are indicative of compromised blood-brain 
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barrier (BBB) or inflammation in EAE models and MS, which results in vasogenic edema [18-
22]. More accurate and novel approaches have recently been introduced to distinguish coexisting 
pathologies, including neuroinflammation, axonal injury or pathologieas in gray matter using 
diffusion basis spectrum image (DBSI) or diffusion kurtosis image (DKI) [23-26].    
In addition, functional deficits are highly associated with or prior to aforementioned 
morphologies. MRI, also indeed, holds potential to reveal functional integrity. For instance, 
blood oxygen level dependent (BOLD) fMRI has been applied to study brain plasticity and 
cortical activation in MS patients [27-30] to reflect motor or visual functional deficits. Since 
conventional BOLD fMRI relies on local modulation of tissue blood volume and blood flow, 
secondary to neuronal activation and metabolic demand, it is an approach which is largely 
limited to cortical and gray-matter regions [31, 32] and mainly reflects post-synapse potential in 
cortical region [33, 34]. In addition to post-synapse potential, action potential, the visual signal 
propagation in CNS, should be considered as well to understand and assess functional deficits 
because optic neuritis is prominently affected in optic nerve tracts.  
 Recently, diffusion fMRI has been introduced and suggested as  an alternative approach 
to identify neuronal and axonal functional integrity directly [35-40] Especially for white matter 
tracts, diffusion fMRI offers a promising means to assess axonal function, since our previous 
report showed a significant 27% ADC decrease was observed during visual stimulation in 
healthy mouse optic nerves. Activation-associated ADC decreases in optic nerves were 
independent of any vascular contribution [36].  
White-matter tracts are prominently affected in MS, leading to various level of 
neurological disability.  It is estimated that ~ 66% of MS patients will experience an episode of 
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optic neuritis at some point during the course of the disease (National MS Society, 
www.nationalmssociety.org). A direct and non-invasive assessment of axonal function in optic 
nerves would be crucial in understanding the MS pathophysiology and evaluating therapeutic 
outcomes. In this study, diffusion fMRI was performed to investigate in vivo axon-function 
deficits in EAE optic nerves. 
 
5.2 Materials and Methods 
All experimental procedures involving animals were approved by Washington 
University’s Animal Studies Committee and conformed to the NIH Policy on Responsibility for 
Care and Use of Animals. 
5.2.1 Experimental autoimmune encephalomyelitis (EAE) mouse model  
Fourteen 7-week-old, female C57BL/6 mice were obtained from Jackson Laboratory (Bar 
Harbor, ME). Before immunization, mice were housed with 12-hour dark/light cycle for a week. 
Mice were randomly separated into two groups: seven in the EAE group and seven in the sham 
group. The mice in the EAE group were immunized with 50 µg MOG35-55 peptide emulsified 
(1:1) in incomplete Freund’s adjuvant (IFA) and Mycobacterium tuberculosis. Pertussis toxin 
(300 ng; PTX, List Laboratories, Campbell, CA) was injected intravenously on the day of 
MOG35-55 immunization and two days later. The mice in the control group underwent the same 
procedure with only IFA without MOG35-55 immunization.  
5.2.2 Visual Acuity (VA) 
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Mouse visual acuity was assessed using the Virtual Optometry System (Optomotry, 
Cerebral Mechanics, Inc., Canada). Briefly, the virtual rotating columns were projected on the 
LCD monitors with different spatial frequencies in cycles/degree (c/d). The mouse head 
movement in response to the virtual column rotations was noted. The spatial frequency was 
changed starting from 0.1 c/d with step size of 0.05 c/d until the mouse stopped responding. The 
VA was defined as the highest spatial frequency the mouse was able to respond to the virtual 
rotating columns. Prior to assignment of mice to EAE or experimental groups, all animals were 
checked to ensure that their visual acuity was within the accepted normal range, 0.37 ± 0.02 
cycles/degree (mean ± S.D.), which was similar to our previous report, 0.38 ± 0.003 c/d [23].  
After immunization, VA was assessed daily in all mice.  For animals in the EAE group, VA ≤ 
0.25 c/d (typically 8 – 13 days post-immunization) was defined as the onset of acute optic 
neuritis [23].  For EAE animals, diffusion fMRI measurements were performed on the first day 
at which their visual acuity was observed to be below 0.25 c/d. The mice in sham group did not 
develop visual impairment, but underwent the diffusion fMRI procedure within the same time 
range (8 – 13 days post-immunization)        
5.2.3 Animal anesthesia and set-up 
For initial setup mice were anesthetized with 1.5% isofluorane in O2.  Anesthetized mice 
were placed in a custom-made stereotactic head holder.  The animal’s experimental eye remained 
open and the contralateral eye was covered with parafilm and two layers of black electrical tape. 
After careful setup the mouse and head holder were placed in the imaging cradle. Respiratory 
rate and body temperature were monitored during experiments using an MR-compatible animal-
monitoring system (SA Instrument, Inc., Stony Brook, NY). The body temperature was 
maintained at 37 ± 0.5 ºC via a regulated circulating warm water pad underneath the mouse body 
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and regulated warm air blown into the magnet bore. When mouse respiration was stable, a 
subcutaneous 0.3 mg/kg bolus of medetomidine was administered followed immediately by a 
continuous infusion of medetomidine at a rate of 0.6 mg/kghr through an in-dwelling 
subcutaneous catheter.  Isoflurane in the breathing-gas mixture was gradually discontinued 
according to previously-described protocols until the animals were breathing room air [41].  
5.2.4 Diffusion-weighted Image (DWI) protocol 
MRI experiments were performed on a 4.7-T Agilent DirectDrive
TM
 small-animal MRI 
system (Agilent Technologies, Santa Clara, CA) equipped with a Magnex/Agilent HD imaging 
gradient coil (Magnex/Agilent, Oxford, UK) capable of pulsed-gradient strengths of up to 58 
G/cm and a gradient rise time ≤ 295 µs. An actively-decoupled 1.7-cm receive coil [42] was 
placed on the top of the mouse head for MR signal reception. Then, the animal holder assembly, 
including the receive coil was placed inside an 8-cm actively-decoupled volume transmit coil.  
DWI measurements were carried out as previously described [36]. In brief, a multi-echo 
spin-echo diffusion-weighted imaging sequence [43] was employed with following parameters: 
TR = 1.5 s, TE = 37.1 ms, inter-echo delay = 23.6 ms, FOV = 20 × 20 mm
2
, matrix size = 256 × 
256 (zero-filled to 512 × 512), slice thickness = 1.3 mm. To get the final target image plane and 
minimize partial volume effects, three middle-sagittal DWI images (diffusion gradient applied in 
the slice-select direction) were acquired based on image planning derived from axial T2-
weighted images. The middle slice of the three sagittal DWI images clearly showed the 
orientation of the pair of optic nerves, and the final image plane was adjusted carefully based 
upon this middle sagittal DWI. The final targeted image slice plane was orthogonal to the optic 
nerves to minimize partial volume effects. Two diffusion-sensitizing factors (b values), 0.1 and 
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1.4 ms/µm
2 (with δ = 5 ms and Δ = 18 ms), were applied to generate two DWIs (Fig. 5 – 1A and 
5 – 1B). A train of three echoes were co-added to form the final MR images to increase 
accumulated signal-to-noise ratio.  
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Figure 5 – 1 Two diffusion-weighted images (DWI) with diffusion-sensitizing gradients applied 
in the phase-encoding direction (left-to-right) with b values of 0.1 ms/µm
2
 (A) and 1.4 (B) 
ms/µm
2
 were used to generate the resulting ADC map (C). The red box in panel B highlights 
the location of optic nerves (bright) and surrounding cerebrospinal, which is highly 
suppressed.ADC values in the optic nerves are considerably lower than that in other brain 
tissues.  The regular (nearly circular) shape of the optic nerves suggests good orthogonality 
between the nerve axes and the slice plane, which minimizes partial volume effects.   
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5.2.5 Visual stimulation 
Visual stimulation was delivered by a flashing white LED (Cree, Model C503C-WAS) 
placed 5 cm in front of mouse nose. A step-function signal of 1.4 Hz frequency with 200 ms 
on/514 ms off and 4 V/0 V (on/off) was provided during stimulation. The detail of equipment 
set-up was the same as that reported previously [36]. 
5.2.6 Diffusion fMRI strategy 
For each mouse, three pairs of diffusion-weighted images were acquired. The first pair of 
images without visual stimulation was taken as a baseline. Then, the stimulus-on DWI dataset 
was acquired during application of flashing-light stimulation. Finally, the LED light was turned 
off for the post-stimulus DWI acquisition.  
5.2.7 DWI Data analysis 
For measurements of diffusion perpendicular to the axonal fibers, signal decay with b-
value between 0.1 and 1.4 ms/µm
2
 is monexponential [36]. ADC maps were generated from the 
pair of DWIs according to equation of Skejskal and Tanner [44] with code developed in-house 
and written in MATLAB (Mathworks, Natick, MA).  Optic nerve ROIs were drawn based on 
operator-independent criteria as described previously [36].  
5.2.8 Immunohistochemistry (IHC) staining in optic nerves 
Following MR experiments, mice were perfused with 1 % phosphate-buffer saline (PBS) 
followed by 4 % paraformaldehyde in 1 % PBS. The brain was excised and post-fixed in fixative 
for 24 hours then transferred to 1 % PBS for storage at 4˚C until histological analysis. Mouse 
optic nerves were embedded in 2 % agar blocks [45]. Then, the agar block was embedded in 
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paraffin wax and 5-µm thick transverse slices were sectioned for IHC staining. Sections were 
deparaffinized, rehydrated, and then blocked using 1 % bovine serum albumin (BSA, Sigma Inc., 
MO, US) and 5 % normal goat-serum solution for 20 minutes at room temperature to prevent 
non-specific binding and to increase antibody permeability. Slides were incubated overnight at 
4˚C with monoclonal anti-phosphorylated neurofilament antibody (SMI-31; 1:1000, Covance, 
U.S.) to stain non-injured axons or rabbit anti-myelin basic protein (MBP) antibody (1:1000, 
Sigma Inc., MO, U.S.) to stain myelin sheaths [46-48]. After rinsing, goat anti-mouse IgG or 
goat anti-rabbit IgG conjugated Alexa 488 (1:800) were applied to visualize immunoreactivity of 
phosphorylated neurofilament and MBP. Finally, slides were covered using Vectashield 
Mounting Medium with 4’,6-diamidino-2-phenylindole (DAPI, Vector Laboratory, Inc., 
Burlingame, CA) to stain cell nuclei as well [48, 24]. Histological slides were examined with a 
Nikon Eclipse 80i fluorescence microscope equipped with 60× water objective, and images were 
captured with a black-and-white CCD camera with MetaMorph software (Universal Imageing 
Corporation, Sunnyvale, CA) from the center of optic nerve. The 60× IHC staining images 
(0.018 mm
2
) covered ~40% area of whole optic nerves (0.045 ± 0.013 mm
2
, mean ± S.D.). 
Histological counts are reported for 7 EAE and 6 sham optic nerves in this study. 
5.2.9 Histological data analysis 
The whole field of SMI-31, MBP, and DAPI staining images at 60× magnification were 
captured with the same fluorescence light intensity and exposure time. All captured images were 
converted to 8- bit gray scale and analyzed using threshold, analyze particles and gray level 
watershed segmentation functions in ImageJ (http://bigwww.epfl.ch/sage/soft/watershed/). 
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Positive DAPI staining represented cell nuclei, and larger spots were shown in staining 
images. DAPI-stained regions showed obvious contrast to the background, thus the quantified 
number was directly calculated after applying the signal threshold. 
5.2.10 Statistical analysis 
The p-values of ADC change between first off (baseline) and stimulus on came from a 
cluster linear repeated measures model, which took into account that there were three time points 
for each eye and two eyes per mouse. The p-values of visual function (VA), SMI-31, MBP, and 
DAPI were from nonparametric test for difference between sham and EAE groups and adjusted 
using Wilcoxon Two-Sample Test. The correlation coefficients for VA with each of SMI-31, 
MBP, DAPI, and decreased ADC were analyzed by Spearman’s rank correlation coefficient. 
 
5.3 Results 
5.3.1 Impairment of visual function and reduced activation-associated ADC response in EAE 
optic nerves 
Visual acuity (VA) of EAE and sham animals was assessed daily. Our previous report 
mentioned that normal VA of C57BL/6 mouse was 0.38 ± 0.03 c/d (mean ± S.D., n=30). The 
operational definition of onset acute optic neuritis was VA ≤ 0.25 c/d [23]. Before immunization, 
normal VA was confirmed for each eye (n = 28, VA = 0.37 ± 0.02 c/d) to exclude mice with 
poor vision due to uncontrollable factors. For the EAE mice in this study, the first time point at 
which VA ≤ 0.25 c/d was observed, the operational definition of onset acute optic neuritis in this 
animal model,was between day 8 – 13 post-immunization.  Affected mice developed unilateral 
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visual impairment. Group-averaged visual acuities of the EAE, sham and blocked eyes (n= 7, 7, 
and 14, respectively) were 0.15 ± 0.08, 0.36 ± 0.02, and 0.36 ± 0.03 c/d (mean ± S.D., Fig. 5 – 
2A).  VA of EAE eyes showed a significant 58% (p < 0.005, EAE vs. sham) decrease at the 
acute-stage time point when diffusion fMRI was performed.  
ADC maps were generated from the diffusion-weighted image data (Fig. 1). The group-
averaged baseline optic-nerve ADC of affected acute-stage EAE optic neuritis eyes was higher 
than in sham eyes (Fig. 5 – 2B and 5 – 2C, Table 5 – 1) Compared to their own baseline ADC 
measurements, EAE and sham eyes showed a slight 7% (p = 0.45) and significant 25% (p < 
0.005) ADC decrease during visual stimulus, respectively. No ADC changes were observed 
between baseline and visual stimulus in the contralateral blocked eyes of EAE (p = 0.91) and 
sham (p = 0.97) mice (Fig. 5 – 2B and 5 – 2C, Table 5 – 1) during applied visual stimulation.  
These results imply that the activation-associated ADC decreases in EAE and sham optic nerves 
are elicited by axonal activation.  The EAE eyes exhibited impaired visual acuity and 
correspondingly reduced ADC response with visual stimulation.  
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Figure 5 – 2 In this mouse model of EAE optic neuritis, visual deficits typically developed in 
only one eye.  (A) Group-averaged visual acuity was significantly decreased by 58% (p < 0.005, 
vs. sham, mean ± S.D.) in affected EAE eyes (n=7) compared with the normal vision of sham 
eyes (n=7).  Error bars indicate standard deviation.  Also shown in A is the visual acuity of 
contralateral blocked (n=14) eyes, which were used as a diffusion fMRI internal control for each 
animal. (B) Group ADC maps were generated by averaging stacked ADC maps from EAE 
(n=7) and sham (n=7) optic nerves, respectively (B). The baseline ADC of EAE optic nerves 
(panel B and C) was higher than sham group due to demyelinated vasogenic edema in acute 
stage (cf. Figure 3). Activation-associated ADC decrease was observed in both EAE and sham 
optic nerves (B and C). (C) When compared to its own baseline, ADC significantly decreased 
in sham optic nerves (25%, p < 0.005, B, C, and Table 1) with visual stimulation. In contrast, 
only a slight ADC decrease was observed in EAE optic nerves (7%, p = 0.45, B, C and, Table 
1). The optic nerves of blocked eyes showed no ADC change with visual stimulation (C and 
Table 1), suggesting that the decreased ADC in stimulated EAE and sham optic nerves was 
caused by axonal activity. 
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Table 5 – 1  
Group averaged ADC
┴
 of baseline, stimulus on, and stimulus off of EAE 
(n=7), sham (n=7), blocked EAE and sham (n=14) eyes  
Baseline 
EAE 
Sham 
Blocked  
0.200 ± 0.012 
Stimulus on Stimulus off 
0.171 ± 0.014 
0.188 ± 0.006 
0.186 ± 0.015 
0.128 ± 0.008 
0.189 ± 0.007 
0.207 ± 0.012 
0.164 ± 0.016 
0.196 ± 0.007 
ADC
┴
 (µm2/ms): mean ± standard error of the mean 
Blocked: contralateral EAE and sham eyes 
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5.3.2 Axonal impairment was assessed by immunohistochemistry (IHC) staining  
Previously, immunohistochemical (IHC) staining of phosphorylated neurofilament (SMI-
31, intact axon), myelin basic protein (MBP, myelin sheath), and 4’,6- diamidino-2-phenylindole 
(DAPI, cell nuclei) have been shown to reflect white-matter integrity [46, 7, 24]. Representative 
zoom-in  60× images (56% of 60× image) from EAE (n=7) optic nerves demonstrated obviously 
axonal beading, low density of intact axons, less/thin myelin area, and higher cell nuclei density 
(Fig.5 – 3A, 5 – 3D, and 5 – 3G) than sham optic nerves (n = 6, one optic nerve specimen was 
damaged during tissue processing). Group-averaged counts of SMI-31, MBP, and DAPI (Fig. 5 – 
3C, 5 – 3F, 5 – 3I and Table 5 – 2) in EAE optic neuritis onset showed a significant 22% [p < 
0.005, 5.3 (± 0.6) × 10
5
] decrease in density of intact axons and 17% [p < 0.005, 36.2 (± 2.5)] 
myelin sheath area decrease compared with sham group [6.8 (± 0.5) × 10
5
 and 43.6 (± 2.), 
respectively] . Furthermore, the density of cell nuclei in EAE optic neuritis onset was increased 
by 38% [p < 0.05, 5.8 (± 1.2) × 10
3
] compared with sham group [4.2 (± 0.5) × 10
3
]. Based on 
IHC histological results, EAE optic nerves exhibited clear signs of axonal injury, demyelination, 
and inflammation.  
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Figure 5 – 3 Representative 60× immunohistochemistry staining images of phosphorylated 
neurofilament (SMI-31, intact axon), myelin basic protein (MBP, myelin sheath), and 4’, 6-
dianidino-2-phenylindole (DAPI, nuclei) from EAE (A, D, and G,) and sham (B, E, and H) optic 
nerves. EAE optic nerves demonstrated obvious axonal beading, lower axonaldensity (A), 
reduced myelin area (D), and more cell nuclei (G). Group average IHC counts of EAE (n=7) and 
sham (n=6) optic nerves (Table 2) reveal significant SMI-31 (C) and MBP (F) decrease and 
significant DAPI (I) increase in the EAE group. IHC results suggest that axonal impairment, 
demyelination, and inflammatory infiltration all contribute to visual deficits in acute optic 
neuritis in this EAE mouse model. 
Scale Bar: 25 µm 
* indicates p < 0.005  
** indicates p< 0.05 
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Table 5 – 2  
Quantitative immunohistochemistry results of EAE (n=7) and sham (n=6) 
optic nerves 
SMI31 
(#/mm2) 
Sham (n=6) 
EAE (n=7) 532897 ± 58103 
DAPI 
(#/mm2) 
684574 ± 46864 43.60 ± 2.11 
36.15 ± 2.50 5819 ± 1160 
4225 ± 545 
MBP 
(area %) 
Counts: mean ± standard deviation 
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5.3.3 Pathological trend and activation-associated ADC reduction 
Visual function (measured by VA) highly correlated with intact axon density (Fig. 5 – 4A, 
r = 0.77, p = 0.0012), myelin sheath area (Fig. 5 – 4B, r = 0.92, p < 0.0001), and cell nucleus 
density (Fig. 5 – 4C, r = -0.73, p = 0.0029) assessed by positive SMI-31, MBP, and DAPI stains. 
Our data suggested that impairment of optic nerve function resulting from axonal injury, 
demyelination, and inflammation contributed to decreased VA at the acute stage. The reduction 
of activation-associated ADC decrease was consistent and correlated well with impaired visual 
function (Fig. 5 – 4D, r = 0.76, p = 0.0015) and suggested that diffusion fMRI provides a means 
to non-invasively assess axonal-activation and axonal dysfunction resulting from pathological 
changes in onset optic neuritis in this EAE mouse model.  
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Figure 5 – 4 Pathological changes accompanying decreased visual acuity included reduced SMI-
31 counts (A, intact axon) and MBP (B, myelin area) and increased DAPI counts (C, cell nuclei). 
The reduced activation-associated ADC change (decrease in ADC with stimulation expressed 
as a percentage of baseline ADC) accompanied lower visual acuity (D). This data suggests that 
axonal impairment and dysfunction can be assessed by diffusion fMRI. 
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5.4 Discussion 
This is the first study applying diffusion fMRI to assess functional deficits of a white-
matter tract in vivo. The results presented here demonstrate a slightly attenuated, 7%, neuronal-
activation-associated ADC decrease in EAE mice with onset optic neuritis compared to a 
significant, 25%, decrease in sham mice.  The results for EAE sham mice are comparable to our 
previously-reported ~27% ADC decrease in normal mouse optic nerves [36]. The attenuated 
activation-associated ADC response in the current study is consistent with impaired visual 
function resulting from optic-nerve pathologies including axonal injury, demyelination, and 
inflammation.  
Visual signal conduction through the optic nerve depends on repeated cycles of 
membrane depolarization/action potential/repolarization, which are accompanied by ion gradient 
changes [49].Unlike BOLD fMRI is largely limited to gray matter for post-synaptic potential [33, 
34], diffusion fMRI reveals the effect of action potential propagation in white matter. Diffusion 
MRI would be expected to be sensitive extracellular space (ECS) shrinkage caused by transient 
ionic gradient changes, osmotic shifts of water across cell membranes, or glial cell swelling 
associated with changes in size and shape during axonal activation [50-56, 39, 57, 58]. In our 
previous study, the observed activation-associated 27% ADC decrease was shown to be 
independent of a  vascular-coupling contribution [36]. Diffusion fMRI has the potential to 
directly probe functional integrity in CNS axons without confounding blood-flow effects.  
In this study, we measured VA by optokinetic response (OKR) for EAE and sham eyes to 
reflect visual function, since VA with different spatial frequency in C57BL/6 mice reflected the 
retinal efferent pathway to subcortical visual structures [59, 60]. Because psychophysical 
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measurement, i.e. OKR, is taken 70% correct level compared to electrophysiological 
measurement, i.e. VEP [61], VA by OKR measurement, therefore, reflects appropriately 
electrical signal propagation in mouse visual system. The VA of EAE eyes in this sample was 
significantly lower than in sham eyes (a 58% decrease, p < 0.005, Fig. 5 – 2A). The histological 
results showed that the EAE mice in this sample developed inflammation, demyelination, and 
axonal injury (Fig. 5 – 3C, 5 – 3F, and 5 – 3I), suggesting the pathologies of optic neuritis in 
EAE mice affected their visual function. 
According to VEP measurement in mouse visual system, the optimal visual stimulation 
condition was determined [61] and applied to this study. During diffusion measurement with 
visual stimulation, decreased ADC and unchanged ADC were observed in unblocked and 
blocked eyes of sham mice, respectively (Fig. 5 – 2B and 5 – 2C) suggesting the ADC directly 
revealed electrical/action potential in optic nerve. For the unblocked eyes, the ADC change in 
EAE optic nerves was less than sham mice and revealed that the dysfunction of axonal activity. 
The results corresponded to lower VA and pathologies. The baseline of ADC in EAE optic 
nerves may result from acutely demyelination or vasogenic edema since radial diffusivity or 
ADC increase reflected those two pathologies have been reported  in EAE mice or MS patients 
[14, 7, 23, 19, 62, 63].  
In CNS, compound action potential (CAP) propagation causes ion gradient change and 
needs large amount of ATP to maintain ion homeostasis and neurotransmission including about 
60-80% and 10-20% ATP consumption, respectively [64].  Mitochondria are the major source of 
axonal ATP required to maintain CAP propagation by means of saltatory conduction [65]. At 
acute stage of MS patients and EAE animal models, lymphocytes cross BBB and attack myelin 
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in CNS [3]. Lymphocyte-induced inflammation activates microglial cells and macrophages and 
then induced more nitric oxide (NO), which also blocks saltatory conduction propagation and 
reduces mitochondrial function in CNS of MS patients and EAE animals [66-68]. Demyelination, 
which also leads to impaired saltatory conduction [69, 70], has been shown to result in, 
redistribution of and/or increases in voltage-gated Na
+
 channel density in the membrane of 
demyelinated axons in order to maintain nerve conduction, and it leads to increased energy 
demands due to altered channel expression and demyelination [71, 70, 72]. Therefore, inhibition 
of mitochondrial due to NO production and increase of energy demand due to Na
+
-channel 
redistribution might result in ion dyshomeostasis and energetic imbalance. Declining energetic 
status results in reduced Na
+
/K
+
 ATPase pump activity and, hence, increases intracellular Na
+
 
concentration.  In such situations, Ca
2+
 influx via action of the Na
+
/Ca
2+
 exchanger has been 
postulated to produce mitochondrial dysfunction, axonal damage, and ultimately necrosis [73, 74, 
66, 71, 75]. Other mechanism such as the excessive glutamate production by inflammatory cells 
leads to glutamate-induced Ca
2+
 overload and inhibition of mitochondria, and it finally results in 
excitotoxicity of axons [76, 75, 77, 71]. Therefore, we speculate that the inflammation, 
demyelination, ion-dyshomeoastasis, and energetic imbalance in CNS of MS patients or EAE 
animals affect functional integrity and could be an early event.   
Our histological results demonstrated that EAE optic nerves in this sample developed 
axonal injury, demyelination, and inflammation (Fig. 5 – 3); the pathologies were consistent with 
impaired visual function as well (Fig. 5 – 4A ~ 5 – 4C). The results were in agreement with 
aforementioned impaired visual signal propagation in MS patients or EAE animals. The change 
of decreased activation-associated ADC response was consistent with impaired visual acuity 
(Fig. 5 – 4D). Therefore, this non-invasive in vivo functional measurement may offer a new 
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approach to directly reflect the axonal activity. Contributions from retinal dysfunction at the 
early time point measured herein are unlikely as previously retinal ganglion cell (RGC) 
pathological changes have been shown to occur later in the progression of optic neuritis [78, 79].  
This is also consistent with our own RGC histological data (Chiang et al., unpublished).  
 Optic neuritis is frequently the first sign of MS in patients [4]. Inflammation and 
demyelination of the affected optic nerves produces impaired visual function (blurred vision or 
occasionally total blindness).  In EAE animal models of MS, several groups demonstrated visual 
dysfunction accompanying optic neuritis via behavioral or visual evoke potential (VEP) 
measurements [80, 81, 8, 82].  These measurements rely upon functionality of the entire visual 
pathway including retina, optic nerve, visual cortex, and/or conscious response of the brain.  
Thus they may lack specificity in terms of demonstrating the location and contribution of 
specific lesion sites.  Because ADC of diffusion fMRI is a direct measurement of white-matter 
function, hence, we speculate that activation-associated ADC decrease, which likely result from 
ECS shrinkage during axonal activation, in EAE optic nerves is less than sham mice during 
visual stimulation. Decreased ADC change was observed in EAE optic nerves since they bear 
dysregulation of ion gradients and ion dyshomeostasis owing to mitochondrial failure and 
demyelination. That is, the EAE optic nerves with prolonged or impeded CAP propagation lose 
the abilities to modulate transient ion gradient change and osmotic shift of water across cell 
membranes.  
To conclude, the attenuated activation-associated ADC response at the onset of optic neuritis in 
this animal model likely reflects in vivo functional deficits at the optic-nerve axonal level. The 
impaired EAE optic nerves demonstrated an attenuated response compared to sham optic nerves 
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during application of the same stimulation protocol. The functional pathologies in EAE optic 
nerves using diffusion fMRI provide a unique perspective on the consequences of inflammatory 
demyelinating pathologies. In vivo diffusion fMRI is a promising tool for investigations of 
pathological mechanisms, therapeutic targets, and/or longitudinal assessment in white-matter 
tracts.  
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Chapter 6 
Conclusion 
Optic neuritis is frequently the first sign of multiple sclerosis (MS). The pathologies 
result from lymphocytes crossing blood-brain barrier (BBB) and then attacking myelin in central 
nervous system (CNS) and, finally, lead to inflammation, demyelination, and axonal injury [1]. 
Better understanding of the mechanism and relationship of optic neuritis and MS will lead to 
more efficient treatment strategies. Recently, MRI has been widely used as a non-invasive 
approach to detect and diagnose the morphological changes of MS over several decades to track 
or diagnose the disease process [2-5]. Functional deficits might be an early pathological event 
that precedes the morphological changes. However, currently the most commonly used 
functional test is BOLD (blood oxygen level dependent) fMRI, which mostly focuses on cortical 
regions, but is limited in the analysis of white-matter function [6]. Magnetic resonance imaging 
(MRI) can reflect different physical properties in tissues, such as T1, T2, and water diffusivity. 
We further took advantage of these properties to dynamically investigate in vivo functional 
activity in EAE mice, the mouse model of MS, which also develops optic neuritis. 
6.1 Axonal transport using manganese-enhanced MRI (MEMRI) 
Axonal transport, the transport of proteins and organelles within the axons, is crucial to 
maintaining normal neuronal function. There are multiple reports in the literature that axonal 
transport dysfunction or disruption is an early event of neurodegenerative disease, such as 
Alzheimer’s disease [7]. However, few studies focus on the integrity of axonal transport in MS 
patients or experimental autoimmune encephalomyelitis (EAE) animal models. Therefore, 
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investigating axonal transport in the EAE mice might provide pathological information about MS 
before morphological changes. Manganese-enhanced MRI (MEMRI) is a promising tool to tract 
dynamic Mn
2+
 transport within visual system which will allow us to investigate axonal transport 
in vivo. Since Mn
2+
 is paramagnetic, MEMRI provides obvious contrast on T1-weighted (T1W) 
image and as a Ca
2+
 analogue it can enter neurons via voltage-gated Ca
2+
 channels and be 
transported down the axon[8, 9]. However, the cellular toxicity of Mn
2+
 has long been 
recognized as overexposure causes Parkinsonism [10]. Hence, it is important to determine the 
Mn
2+
 dosage which maximizes MR detectability and minimizes toxicity. Therefore, before we 
apply MEMRI to EAE mice, the optimized dosage for mouse visual system is needed.  
In Chapter 2, we compared topical loading with intravitreal injection of MnCl2 for 
MEMRI of mouse optic nerve to determine the optimal concentration and volume of MnCl2 dose. 
Visual functional was assessed longitudinally. In vivo MEMRI and diffusion tensor imaging 
(DTI) of optic nerves as well as the T2-weighted (T2W) MRI of mouse retina were used to 
assess the integrity of visual system tissue after MnCl2 loading. After MRI studies, postmortem 
histology was performed to validate in vivo MRI findings. The results revealed that the 
previously suggested safe dose for intravitreal injection of MnCl2 caused transient retinal 
swelling and visual acuity impairment with full recovery within one day in mice. In contrast, the 
literature reported dose for topical MnCl2 loading caused adverse degeneration of photoreceptors  
and significantly impaired visual acuity in mice. We not only examined the toxicity of MnCl2 
loading, but also demonstrated the utility of in vivo MRI contrast as a surrogate marker of visual 
system tissue integrity.  
In Chapter 3, we compared the axonal transport rate in EAE and sham mouse optic 
nerves using MEMRI with an intravitreal injection of 0.25 μL of 0.2 M MnCl2: the optimal 
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dosage that was determined in Chapter 2. In order to understand the mechanism of functional 
deficits at the acute stage, we defined and determined the onset of optic neuritis by mouse visual 
acuity using the Virtual Optometry System (Optomotry, Cerebral Mechanics, Inc., Canada). 
MEMRI was performed in EAE eyes as soon as visual acuity dropped (~ 11.3 ± 1.9 days post-
immunization). The mice in the sham group did not develop visual impairment but underwent 
the same MEMRI procedure at the similar time range. During the MEMRI procedure, mice were 
directly put in the scanner after intravitreal injection. A series of 3D-T1W images was acquired 
every 0.55 hour from 0.55 – 5.5 hours post-injection. The quantitative data showed that 
comparing to sham optic nerve, the accumulation rate in EAE mice with moderate and severe 
optic neuritis was significantly decreased by 19% and 38%, respectively. Similarly, the transport 
rate in EAE mice with moderate and severe optic neuritis was significantly decreased when 
compared to sham optic nerve by 43% and 65%, respectively. Postmortem histology confirmed 
the EAE mice with optic neuritis in this sample developed inflammation, demyelination, and 
axonal injury pathologies. The degree of axonal transport deficits correlated well with impaired 
visual function as well as histological pathologies. In conclusion, MEMRI holds potential to 
track in vivo dynamical axonal transport.  
6.2 Axonal Activity using diffusion fMRI 
Another functional component of neuronal function in the visual system is the electric 
transmission of the visual signal via depolarization of different ion channels in optic nerve 
through brain [11]. Myelin plays a role to speed up and conserve signal delivery, so-called 
saltatory conduction. Since MS is a demyelinative disease, the signal propagation should be 
blocked or delayed. Currently, fMRI mainly depends on BOLD signal change to identify neuron 
activity in gray matter indirectly through vascular changes. Several reports have explored 
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functional deficits in gray matter of MS, such as motor and visual cortex [12-15]. However, 
electrical signal propagation also largely relies on white matter, but there have been limited 
studies focusing on it in MS. Since visual conduction leads to repeated cycles of membrane 
depolarization, action potential, and repolarization, these successive effects are highly associated 
with transient ionic gradient changes, osmotic shift of water across cell membranes, and size- 
and shape-related glial cell swelling [16-25]. Finally, those effects might results in the 
extracellular space (ECS) shrinkage. Displacement of water molecules in tissue can be detected 
by diffusion MRI. Le Bihan et al. reported that during visual stimulation, increased signal 
intensity (2%) was observed in diffusion weighted images [26]. That is, apparent diffusion 
coefficient (ADC) was decreased and could be a direct means to reveal neuronal activity. 
However, Miller et al. later reported that the vascular effects also led to ADC decrease without 
visual stimulation [27]. Unlike gray matter, diffusion MRI might be a potential means to reveal 
neuronal activity in white matter due to limited blood flow and blood volume. Hence, ADC 
might be sensitive to stimulation-associated ECS shrinkage, which limits the displacement of 
water molecules. 
In Chapter 4, we gave mice visual stimulation and measured ADCand ADC|| using 
standard diffusion measurement. A 27% stimulus-associated ADCdecrease, which is the ADC 
perpendicular to optic nerve/axonal fibers, was observed. No change ADC||, which is the ADC 
parallel to optic nerve/axonal fibers, was shown. The stimulus-associated ADCdecrease was 
repeatable. To confirm that the ADCdecrease was independent of vascular contribution, we 
performed the same experimental procedure in hypercapnia mice. The results showed that during 
visual stimulation, a significant 20% ADC decrease was observed suggesting there were no 
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vascular effects. Therefore, diffusion measurement in white matter could directly reveal axonal 
activity.  
In Chapter 5, we further applied the diffusion measurement with visual stimulation in 
EAE mice with optic neuritis to assess functional integrity in optic nerves. After immunization, 
daily visual acuity was confirmed by Virtual Optometry System (Optomotry, Cerebral 
Mechanics, Inc., Canada). Diffusion fMRI was performed in EAE eyes as soon as visual acuity 
dropped (~ 10.6 ± 1.7 days post-immunization). The mice in the sham group did not develop 
visual impairment but underwent the same diffusion fMRI procedure at the similar time range. 
The results showed that visual stimulation produced a significant 25% stimulus-associated ADC 
decrease in sham mice, which is comparable of our previous report in normal mice (~27%). Only 
a statistically insignificant 7% stimulus-associated ADC decreased was seen in acute-stage EAE 
mice. The reduced ADC response was consistent with impaired visual function (lower visual 
acuity) and histological pathologies including axonal inflammation, demyelination, and axonal 
injury. The results also implied that diffusion fMRI holds promise for directly gauging in vivo 
white-matter dysfunction.   
6.3 Conclusion 
To conclude, axonal transport disruption and axon-activity dysfunction, at optic neuritis 
onset in EAE mice were confirmed by MEMRI and diffusion fMRI, respectively. These 
functional deficits were highly correlated with impaired visual function and morphological 
changes. Therefore, non-invasive MRI not only provides a way to reflect morphological changes 
but also holds potential to assess functional integrity in white matter.         
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Introduction  
Manganese enhanced MRI (MEMRI) has been widely applied to 
investigate axonal transport in the rodent visual pathway. Intraocular 
injection is an established approach for MnCl2 loading.  Bearer et al. [1] 
have reported the impaired visual evoke potential (VEP) at the lowest 
intraocular dose allowing detectable MEMRI effect. In a recent report, 
the noninvasive topical MnCl2 loading [2] was demonstrated without 
the need of invasive intraocular injection of MnCl2. However, the effect 
of topical MnCl2 loading on visual function was not evaluated. In this 
study, the toxicity of MnCl2 was evaluated by visual acuity (VA) 
measurement [3,4] as well as optic nerve and retina MRI.  
Material and Method 
Four groups of female C57BL/6 mice at 8 weeks of age were examined: control 
(n=4), 0.5 (n=4), 0.75 (n=6), and 1 M (n=5) of MnCl2 loading. Mice were 
anesthetized using 1.5% isoflurane/oxygen for topical loading of 20µl of MnCl2 on 
the right eye. An additional 20µl of MnCl2 was applied every 20 min to compensate 
the volume loss due to evaporization.  The body temperature was maintained at 37 
ºC during loading with an electric heating pad. After an hour, a lint free tissue was 
used to remove the solution. Twenty-four hours after loading, mice were 
anesthetized and imaged on a 4.7 T animal scanner using a 3D gradient echo 
sequence with the following parameters: TR 15ms TE 2.63ms, flip angle 20, 
number of averages 16, FOV 15 × 15 mm2, and matrix size 128 × 128 × 64 (zero-
filled to 256 × 256 × 64 ). Region of interest (ROI) included retina, optic nerve 
(ON), and superior colliculus (SC).  Visual acuity (VA) was assessed daily from 
1 to 7 days. Optic nerve were imaged on 4.7 T animal scanners with multiple-echo spin-ehco 
diffusion weighted sequence at days 1 and 7 with the following parameters: TR 1.5s, TE 34 ms, 
inter-ehco delay 19 ms, FOV 22.5 × 22.5 mm2 , matrix size 192 × 192 (zero-filled to 384×384 ), 
thickness 0.5 mm.   Retina images were performed on an11.74 T scanner with a standard spin 
echo sequence with the following parameters: TR 2s, TE 34ms FOV 12 × 12 mm2  matrix size 
256 × 256 (zero-filled to 512 × 512). 
Results & Discussion  
 At one day after 0.75 and 1 M MnCl2 loading on right eyes, significant T1W enhancement was 
seen in the right retina, right optic nerve, left lateral geniculate nucleus and left superior colliculus 
(Fig. 1). Only slight enhancement of retina was seen in mice loaded with 0.5M MnCl2. Significant 
visual function impairment was seen in both 0.75 and 1 M MnCl2 loaded eyes (Fig. 2). Upon 1 M 
MnCl2 loading, irreversible VA decreased from normal (VA = 0.4) to complete blindness (VA = 0) 
from 1 day after loading. In 0.75 M MnCl2 loaded eyes, VA decreased to 0.1 (not completely 
blind) at 1 day after and recovered to approximately the normal range at 5 days after loading (Fig. 
2).  There was no detected axonal or myelin injury in optic nerve loaded with 1M MnCl2 at 1 and 
7 days after loading (Fig. 3). However, a significant reduction in retinal thickness (~27% 
compared to the control) was seen in eyes loaded with 1M MnCl2 (Fig. 3).   
Conclusion 
Our data suggested that although topical loading of 1 M MnCl2 did not injure optic nerve, as indicated by normal DTI parameters, the damaged retina was likely 
responsible for the irreversible loss of vision. The reduced retinal thickness may reflect the loss of retinal cells. The success in optic nerve enhancement after loading 
may suggest the retinal ganglion cells were not lost and still capable of uptake Mn2+. Alternately, the retinal ganglion cell was damaged after uptake of Mn2+ and 
transporting to its axon. This is the first time retinal integrity was assessed after MnCl2 loading. 
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Fig. 1  Four representative  axial images  from 3D T1W data 
set one day after  0.75 M MnCl2 loading.  Visual pathway was 
enhanced from (A) right retina,  (B) right optic nerve, (C) left 
lateral geniculate nucleus, and (D) left superor colliculus ; (E) 
oblique  T1W image  that included retina and optic nerve  
showed Mn2+ enhanced signal at right side.  
(E)
Fig. 2 Visual acuity (VA) time course after 0.75 and 1 M MnCl2 loading on 
right eyes. VA irreversibly decreased from normal (0.4) to complete blind 
(0) after 1 M loading. VA decreased to 0.1 (not completely bind) and 
recovered at day 5 after 0.75 M loading. 
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Fig. 3 DTI parameters of optic nerve, indicated by the 
arrow, in (A) RA, (B) radial, and (C) axial diffusivity maps 
after 1 M MnCl2 loading at the right eye were not affected. 
T2W images showed that the right retina (D) after 1 M 
MnCl2 loading was thinner than the control retina (E). 
Thickness decreased by 27 % after MnCl2 loading.  
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Figure 4 Representative 60× SMI31 (intact axon), MBP (myelin 
sheath), and SMI32 (injured axon) staining images from control and 
EAE mouse.  EAE mouse optic nerve showed obviously axon 
beading (SMI31), distorted myelin sheath (MBP), and positive 
SMI32 staining.  
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Figure 1 Averaged visual acuity of EAE (n=7), 
sham (n=7), and contralateral blocked (n=14) 
eyes (measured before MR experiments) 
showed the poor vision of EAE eyes and normal 
vision of sham and blocked eyes.  Note: EAE 
mice in this sample of animals developed 
unilateral visual impairment. 
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Figure 3 Averaged ADC┴ maps of sham, EAE, and contralateral blocked eyes at 
baseline, with and without stimulation (A). Comparing to its own baseline map, sham 
group showed obvious ADC┴ decrease. Statistical ADC┴ average plot (B) was in 
agreement with the pattern of averaged ADC┴ maps (A). A significant 25% ADC┴ 
decrease was observed in sham group. EAE group only showed a slightly 5% 
decrease.  Regarding blocked eyes, there was no difference between the scans of 
baseline and stimulation. 
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Figure 2 Two diffusion-weighted images 
(DWIs) with 0.1 and 1.4 ms/μm
2
 b-values 
were calculated to generate apparent 
diffusion coefficient (ADC┴) map. Yellow box 
indicates the location of optic nerves 
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Introduction 
Conventional fMRI, based on blood-oxygen level dependent 
(BOLD) signal change, to identify neuronal activation is largely 
limited to assess gray matter activation. We have developed a 
diffusion fMRI method to detect white matter functional activation 
in normal, healthy mouse optic nerves and observed a 27% 
decrease in the water apparent diffusion coefficient perpendicular 
to the axonal fibers (ADC⊥) upon flashing light stimulation. 
Meanwhile, we excluded the vascular contributions to the ADC⊥ 
change via measurements in hypercapnic mice [1].  In the current 
study, we extend this method to non-invasively assess the 
response of experimental autoimmune encephalomyelitis (EAE) 
mouse optic nerves to visual stimulation with ongoing optic 
neuritis. Our findings suggest that acute axonal pathologies 
present at the onset of optic neuritis led to decreased axonal 
activation in EAE mice. Thus, diffusion fMRI holds the potential to 
provide a non-invasive assessment of functional integrity of CNS axons.  
 
Materials and Methods  
Animal Model: EAE was induced in seven female ten-week-old C57BL/6 mice 
with MOG35-55
 peptide in complete Freund's adjuvant emulsion. The other 
seven age-matched control mice (sham group) underwent the same 
procedure without MOG35-55 immunization. For EAE mice, daily visual acuity 
(VA) was measured and MR was performed when VA ≤ 0.25 cycle/degree 
(Fig. 1). Typically, this occurs by 9-13 days post-immunization.  Daily VA 
measurements assured normal visual function in control mice [2]. Diffusion-
weighted image (DWI) protocol:  Experiments were performed on a 4.7-T 
Agilent small-animal MR scanner with a multiple-echo spin-echo imaging 
sequence [3] with the following parameters: TR = 1.5 s, TE = 37.1 ms, inter-
echo delay = 23.6 ms, FOV = 20 × 20 mm2, matrix size = 256 × 256 (zero-
filled to 512 × 512), and thickness = 1.3 mm.  The image slice was planned 
carefully to be orthogonal to the optic nerves, thus minimizing partial volume 
effects. A pair of one-direction (perpendicular to optic nerve) DWI was 
acquired with b-value = 0.1 and 1.4 ms/μm2, δ = 5 ms, and Δ = 18 ms. 
Acquisition time was 12.8 minute for each pair of DWI images [1].  Visual 
stimulation: A white LED light was placed 5 cm in front of mouse nose for 
stimulation of the experimental eye. The other eye was covered with parafilm 
and blocked using black electrical tape. Diffusion fMRI strategy: We acquired 
one baseline DWI dataset without stimulation. Then, the stimulus-on DWI dataset was acquired 
during application of flashing light stimulation. Finally, the LED was turned off for last DWI 
acquisition [1].  Data analysis: ADC⊥ maps were generated from two DWIs (Fig. 2). ROI was 
selected using the same determination as our previous study [1]. Histology: mice were perfusion 
fixed immediately after the in vivo MRI for immunohistochemical staining. 
 
Results 
Color-coded group-averaged ADC⊥ maps for the different experimental groups are shown in 
Figure 3A. Group-averaged ADC⊥ at baseline, with and without visual stimulus for EAE, healthy, 
and blocked optic nerves are depicted in Figure 3B.  In healthy optic nerves, application of visual 
stimulus led to a significant ADC⊥ decrease (~25%) while in EAE optic nerves only a slight ADC⊥ 
decrease (~5%) was observed. ADC changes were reversible with cessation of stimulus. 
Blocked eyes showed no difference between baseline and stimulation scans. From Figure 3A it 
can also be appreciated that optic nerves in EAE mice are slightly swollen.  Representative 
SMI31 (intact axons), MBP (myelin sheaths), and SMI32 (injured axons) staining images of optic 
nerves were showed that EAE optic nerve developed axonal beading, distorted myelin sheaths, 
and injured axons (Fig. 4).  
Conclusion 
Our results demonstrate that diffusion fMRI can non-invasively differentiate between patterns of 
in vivo axonal activation in healthy and diseased optic nerve.  Histology of retinal samples is 
ongoing, however, since measurements are made early in the EAE time course, it is likely that the pathology is localized to the optic nerve-- prior to any retinal ganglion cell 
loss [4]. More broadly, with other stimulus paradigms, this technique may enable global detection of white-matter dysfunction throughout the CNS.  
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Figure 1 A serial time-lapse 
oblique corrected T1W images 
from representative mice from 
sham, moderate-ON, and 
severe-ON optic nerves were 
presented to demonstrate the 
different degree of Mn
2+
-
enhancement from 1.1 – 5.5 
hours post-injection.  
Figure 2 For accumulation rate, 
ROIs were drawn on Mn2+-
loading optic nerve and 
reference muscle for each time 
point (A). The slope of each 
normal intensity tend was 
accumulation rate (C). With VA 
decreased, lower accumulation 
rate was shown (E). For 
transport rate, ROI lines were 
drawn on Mn2+-loading and 
contralateral optic nerves (B). 
The slope of each normalized 
displacement trend was 
transport rate in percentage 
optic nerve/hour (D). After 
converting with image 
resolution, transport rate was 
acquired in millimeter/hour (F). 
When VA decreased, lower 
transport rate was observed 
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Introduction 
Multiple sclerosis (MS) is an inflammatory demyelinating disorder of central nervous system (CNS). Frequently, optic neuritis (ON) is an early symptom of MS1. Axonal 
transport deficits are an early event of many neurodegenerative diseases2. However, few reports have assessed axonal transport rate in MS or in experimental autoimmune 
encephalomyelitis (EAE). EAE induced in C57BL/6 mice is a widely used animal model of MS and exhibits many MS-like pathologies, including ON. Mn2+, a Ca2+ analog, is 
paramagnetic to shorten T1 relaxation time and crosses cell membrane trough voltage-dependent Ca2+ channels. Hence, in vivo manganese-enhanced MRI (MEMRI) 
provides a way to investigate real-time axonal transport in rodent visual pathway. In this study, we measured visual acuity (VA) by optokinetic response (OKR) to define onset 
of ON in EAE mice3. Then, MnCl2 was injected in the vitreous of sham and EAE mouse eyes, followed by series of time-lapse T1-weighted (T1W) images to compare axonal 
transport rate. The results suggested that axonal transport impairment was present and correlated with impaired visual functional and pathologies. The results of this study 
showed that axonal transport deficit is an early event of functional deficit of optic nerve in EAE mice. In vivo MEMRI is ideal to investigate axonal transport. 
Materials and Methods  
Animal Model: EAE was induced in 10 female eight-week-old 
C57BL/6 mice with MOG35-55
 peptide in incomplete Freund's 
adjuvant emulsion. The other six age-matched control mice (sham 
group) underwent the same procedure without MOG35-55 
immunization. Daily visual acuity (VA) was measured and MEMRI 
was performed at VA ≤ 0.25 cycle/degree (c/d). According to 
severity of ON, mice were separated into three groups, sham (VA 
= 0.35/0.4 c/d), moderate (VA = 0.2/0.25 c/d), and severe (VA = 0 
c/d) ON. Intravitreal injection: A dose of 50 nmol MnCl2 (0.25μL 
of 0.2 M) was delivered to vitreous space at a rate of 3μL/min with 
34-gaugue needle4. MEMRI: A pair of 8-cm diameter volume and 
1.7-cm diameter surface active-decoupled coils was used. 
Experiments were performed on a 4.7-T Agilent small-animal MR 
scanner with a standard 3D gradient echo sequence with the 
following parameters: TR = 15 ms, TE = 2.63 ms, flip angle = 20º, 
FOV = 15 × 15 × 22 mm3, matrix size = 128 × 128 × 64 (zero-filled 
to 256 × 256 × 128), acquisition time = 32.8 minutes, number of 
signal average = 16, and ten successive sets of 3D-T1W images 
were captured at ~0.55 – 5.5 hours post-injection. B1-
inhomogeneity correction: 3D-T1W image of a 2% agar gel 
phantom was placed underneath surface coil using the same 
acquisition MEMRI parameters with 64 averages. The raw 3D-
T1W image of mouse brain was divided by the 3D-T1W image of 
phantom voxel by voxel using ImageJ to correct B1-
inhomogeneity. Data analysis:  The corrected 3D-T1W image set 
was adjusted and rotated to oblique plane that covered retina and 
optic nerves before chiasm (Fig. 1). Accumulation rate 
calculation: ROIs (region of interest) were drawn on Mn2+-loading 
optic nerves and reference area for all oblique corrected T1W 
images (Fig. 2A). The slope of normalized intensity, calculated by 
ratio of Mn2+-loading ROI and reference area, was accumulation 
rate (Fig. 2C and 2E). Transport rate calculation: ROI lines were 
drawn on Mn2+-loading and contralateral optic nerves for all 
oblique corrected T1W images (Fig. 2B). Arrival of Mn2+ was 
determined by intensity of voxel ≥ threshold (mean + 2SD of 
contralateral ROI line). The slope of normalized displacement 
(number of voxels with Mn2+ arrival), normalized by the whole 
optic-nerve ROI line, was transport rate. After converting with 
image resolution, transport rate was converted to millimeter per 
hour (Fig. 2 D and F).  Histology: mice were perfusion fixed 
immediately after the in vivo MEMRI for immunohistochemical 
staining of the optic nerve. 
Results 
Compared to sham optic nerves, Mn2+ accumulation rate was 
significantly decreased by 19% (p < 0.005, moderate EAe) and 
38% (p < 0.005, severe EAE) (Fig. 2E). The accumulation rate 
was 23% (p < 0.05) slower in the EAE mice with severe ON than that with the moderate ON (Fig. 2E). Compared to sham optic nerves, Mn2+ transport rate was significant 
decreased by 43% (p < 0.05, moderate EAE) and 65% (p < 0.005, severe EAE). Representative TUJ1(microtubule-associated βIII-tubulin, staining the base structure for 
kinesin motor protein movement)5, SMI31 (intact axon), MBP (myelin sheath), and DAPI (cell nuclei) stains showed that EAE optic nerves developed axonal transport deficits, 
axonal injury, demyelination, and inflammation. 
Conclusion 
Our results demonstrate that MEMRI can provide an in vivo real-time quantification of axonal transport in EAE mice at ON onset. In addition to morphological changes, 
functional deficits, such as axonal transport disruption, also occurred at this stage. Preventing the worsening or curing the early axonal transport deficit may be a potential 
treatment target to halt the degeneration of axons in MS. Our results showed the first quantitative assessment of axonal transport in EAE mice suggesting that MRMRI is 
suitable for pre-clinical drug tests.    
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Figure 3 Representative 60x TUJ1 
(βIII-tubulin), SMI31 (intact axon), 
MBP (myelin sheath), and DAPI 
(cell nuclei) staining from sham, 
moderate-ON, and severe-ON optic 
nerves. EAE optic nerves showed 
the sign of axonal transport deficits 
(less microtubule-associated βII-
tubulin), axonal injury (less axon), 
demyelination (less myelin area), 
and inflammation (more cells).  
Scale bar: 25μm 

